Concept1,Concept2,Concept1_URI_withoutiid,Concept2_URI_withoutiid,internal_ID_for_concept1,internal_ID_for_concept2,Code_Concept1,Code_Concept2,Definition_Concept1,Definition_Concept2,concept1_mandatory_or_not,concept2_mandatory_or_not,Relation_URI,Concept_1_URL,Concept_2_URL
Meningioma Ontology,Assessing MRI Sequences,Meningioma_Ontology,Assessing_MRI_Sequences,M_Meningioma_0,M_Meningioma_0,,NCIT_C115501,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",A collection of magnetic resonance image files pertaining to a clinical study.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C115501
Meningioma Ontology,CT finding,Meningioma_Ontology,CT_finding,M_Meningioma_0,M_Meningioma_1,,NCIT_C115499,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",A collection of computed tomography files pertaining to a clinical study.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C115499
Meningioma Ontology,Description of lesion,Meningioma_Ontology,Description_of_lesion,M_Meningioma_0,M_Meningioma_2,,NCIT_C3824,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.","A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C3824
Meningioma Ontology,Histopathological details,Meningioma_Ontology,Histopathological_details,M_Meningioma_0,M_Meningioma_3,,NCIT_C18190,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C18190
Meningioma Ontology,MR imaging equipment utilized,Meningioma_Ontology,MR_imaging_equipment_utilized,M_Meningioma_0,M_Meningioma_4,,NCIT_C115501,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",A collection of magnetic resonance image files pertaining to a clinical study.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C115501
Meningioma Ontology,MRI Features,Meningioma_Ontology,MRI_Features,M_Meningioma_0,M_Meningioma_5,,,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.","In a clinical MRI study comprising a collection of MRI image files, a feature refers to a distinctive, measurable attributeâ€”such as volume, shape, intensity histogram statistics, or texture heterogeneityâ€”extracted from those images to characterize tissue properties quantitatively. These radiomic features are used in computational analyses, often combined with clinical or molecular data, to support diagnostic, prognostic, or predictive tasks",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://pubmed.ncbi.nlm.nih.gov/32060219/
Meningioma Ontology,Operative Details,Meningioma_Ontology,Operative_Details,M_Meningioma_0,M_Meningioma_6,,NCIT_C15329,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.","A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C15329
Meningioma Ontology,Patient investigations,Meningioma_Ontology,Patient_investigations,M_Meningioma_0,M_Meningioma_7,,NCIT_C142430,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.","Any experiment that involves a test article and one or more human subjects, and must either meet the requirements for prior submission to the FDA or the results of which are to be submitted to or inspected by the FDA later as part of an application for a research or marketing permit.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C142430
Meningioma Ontology,Quality assessment of MRI scanners,Meningioma_Ontology,Quality_assessment_of_MRI_scanners,M_Meningioma_0,M_Meningioma_8,,NCIT_C25283,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",An essential and distinguishing attribute of something or someone; a degree or grade of excellence or worth.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C25283
Meningioma Ontology,drugs intake,Meningioma_Ontology,drugs_intake,M_Meningioma_0,M_Meningioma_9,,NCIT_C78139,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.","A laboratory test of biological material such as blood, urine, hair, saliva or sweat, used to detect the presence of a drug or its metabolites with in the body.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C78139
Meningioma Ontology,family history,Meningioma_Ontology,family_history,M_Meningioma_0,M_Meningioma_10,,NCIT_C17726,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,ttp://purl.obolibrary.org/obo/NCIT_C17726
Meningioma Ontology,post operative follow up,Meningioma_Ontology,post_operative_follow_up,M_Meningioma_0,M_Meningioma_11,,C16033,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.","Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033
Meningioma Ontology,presenting symptoms and signs,Meningioma_Ontology,presenting_symptoms_and_signs,M_Meningioma_0,M_Meningioma_12,,NCIT_C100104,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
Meningioma Ontology,surgery,Meningioma_Ontology,surgery,M_Meningioma_0,M_Meningioma_13,,NCIT_C17173,"Meningioma_Ontology is a structured knowledge representation framework that formally organizes and defines the concepts, relationships, attributes, and classifications related to meningiomas â€” tumors arising from the meningothelial (arachnoid cap) cells of the meninges. It provides standardized terms for describing clinical, radiologic, pathologic, molecular, and therapeutic aspects of meningiomas, enabling interoperability across medical datasets, decision-support systems, and research applications.",The branch of medical science that treats disease or injury by operative procedures.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C17173
Meningioma Ontology,Medical History,Meningioma_Ontology,Medical_History,M_Meningioma_0,M_Meningioma_14,,NCIT_C49603,A root class encompassing all concepts in the meningioma ontology. [Source: Custom],"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,http://purl.obolibrary.org/obo/NCIT_C49603
Medical History,Ionizing radiation exposure,Medical_History,Ionizing_radiation_exposure,M_Meningioma_1,M_Meningioma_15,NCIT_C49603,NCIT_C61401,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",The unintentional exposure to radiation of a person.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C61401
Medical History,smoking,Medical_History,smoking,M_Meningioma_1,M_Meningioma_16,NCIT_C49603,SNOMED CT - 77176002,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",The inhalation of smoke from burning tobacco.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,
Medical History,other disease,Medical_History,other_disease,M_Meningioma_1,M_Meningioma_17,NCIT_C49603,NCIT_C2991,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C2991
Medical History,BMI,Medical_History,BMI,M_Meningioma_1,M_Meningioma_18,NCIT_C49603,NCIT_C16358,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",An individual's weight in kilograms divided by the square of the height in meters.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C16358
Medical History,hypertension,Medical_History,hypertension,M_Meningioma_1,M_Meningioma_19,NCIT_C49603,NCIT_C3117,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",Blood pressure that is abnormally high.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C3117
Medical History,hypercholesterolemia,Medical_History,hypercholesterolemia,M_Meningioma_1,M_Meningioma_20,NCIT_C49603,NCIT_C37967,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",A laboratory test result indicating an increased amount of cholesterol in the blood.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C37967
Medical History,Diabetes mellitus,Medical_History,Diabetes_mellitus,M_Meningioma_1,M_Meningioma_21,NCIT_C49603,C2985,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985
Medical History,Hypothyroidism,Medical_History,Hypothyroidism,M_Meningioma_1,M_Meningioma_22,NCIT_C49603,NCIT_C26800,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",Abnormally low levels of thyroid hormone.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C26800
Medical History,neurofibromatosis,Medical_History,neurofibromatosis,M_Meningioma_1,M_Meningioma_23,NCIT_C49603,NCIT_C6727,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","An autosomal dominant hereditary neoplastic syndrome. Two distinct clinicopathological entities are recognized: neurofibromatosis type 1 and neurofibromatosis type 2. Neurofibromatosis type 1 is associated with the presence of cafe-au-lait cutaneous lesions, multiple neurofibromas, malignant peripheral nerve sheath tumors, optic nerve gliomas, and bone lesions. Neurofibromatosis type 2 is associated with the presence of schwannomas, meningiomas, and gliomas.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C6727
Medical History,Renal insufficiency,Medical_History,Renal_insufficiency,M_Meningioma_1,M_Meningioma_24,NCIT_C49603,NCIT_C4376,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C4376
Medical History,Pulmonary disease,Medical_History,Pulmonary_disease,M_Meningioma_1,M_Meningioma_25,NCIT_C49603,NCIT_C3198,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C3198
Medical History,Coronary heart disease,Medical_History,Coronary_heart_disease,M_Meningioma_1,M_Meningioma_26,NCIT_C49603,NCIT_C26732,"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.",Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC),,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C49603,http://purl.obolibrary.org/obo/NCIT_C26732
Who Grade I,Lympho-plasmacytic Rich,Who_Grade_I,Lympho_plasmacytic_Rich,M_Meningioma_2,M_Meningioma_27,NCIT_C38936,NCIT_C4720,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the presence of prominent chronic inflammatory infiltrates that predominate over the meningioma cells.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C4720
Who Grade I,Metaplastic,Who_Grade_I,Metaplastic,M_Meningioma_2,M_Meningioma_28,NCIT_C38936,NCIT_C6907,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.","A WHO grade I meningioma characterized by the presence of a prominent mesenchymal component. The mesenchymal component may be osseous, cartilaginous, myxoid, lipomatous, or a mixture of mesenchymal elements.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C6907
Who Grade I,Secretory,Who_Grade_I,Secretory,M_Meningioma_2,M_Meningioma_29,NCIT_C38936,NCIT_C4718,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the presence of epithelial differentiation and numerous intracellular PAS positive bodies that are rich in glycogen.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C4718
Who Grade I,Micro-cystic,Who_Grade_I,Micro_cystic,M_Meningioma_2,M_Meningioma_30,NCIT_C38936,C41421,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A pathologic process that contains a single or multiple sac-like spaces.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,https://evsexplore.semantics.cancer.gov/evsexplore/search?terminology=ncit&term=Micro-cystic%20lesion&type=contains&fromRecord=0&pageSize=10&source=
Who Grade I,Transitional,Who_Grade_I,Transitional,M_Meningioma_2,M_Meningioma_31,NCIT_C38936,NCIT_C4333,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the coexistence of meningothelial cells and fibrous architectural patterns.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C4333
Who Grade I,Angiomatous,Who_Grade_I,Angiomatous,M_Meningioma_2,M_Meningioma_32,NCIT_C38936,NCIT_C4332,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the presence of small and medium sized vessels that predominate over the meningioma cells,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C4332
Who Grade I,Meningothelial,Who_Grade_I,Meningothelial,M_Meningioma_2,M_Meningioma_33,NCIT_C38936,NCIT_C4329,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the presence of tumor cells that form lobules. The tumor cells are generally uniform. Whorls and psammoma bodies are usually not present.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,
Who Grade I,Fibrous,Who_Grade_I,Fibrous,M_Meningioma_2,M_Meningioma_34,NCIT_C38936,NCIT_C4330,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the presence of spindle cells that form bundles in a collagen matrix.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C4330
Who Grade I,Psammomatous,Who_Grade_I,Psammomatous,M_Meningioma_2,M_Meningioma_35,NCIT_C38936,NCIT_C4331,"A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",A WHO grade I meningioma characterized by the presence of psammoma bodies that predominate over the meningeal cells.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C38936,http://purl.obolibrary.org/obo/NCIT_C4331
Tumor Location,convexity,Tumor_Location,convexity,M_Meningioma_3,M_Meningioma_36,C157120,NCIT_C5292,The anatomic site of the tumor,A meningioma that affects the frontal sulcus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,http://purl.obolibrary.org/obo/NCIT_C5292
convexity,left convexity,convexity,left_convexity,M_Meningioma_4,M_Meningioma_37,,,,,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
convexity,right convexity,convexity,right_convexity,M_Meningioma_4,M_Meningioma_38,,,,,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
Tumor Location,intraventricular,Tumor_Location,intraventricular,M_Meningioma_3,M_Meningioma_39,C157120,NCIT_C5273,The anatomic site of the tumor.,A meningioma that affects the ventricles of the brain.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C5273
Tumor Location,Skull base,Tumor_Location,Skull_base,M_Meningioma_3,M_Meningioma_40,C157120,NCIT_C5272,The anatomic site of the tumor,A meningioma that arises from the skull base.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C5272
Tumor Location,parasagittal,Tumor_Location,parasagittal,M_Meningioma_3,M_Meningioma_41,C157120,NCIT_C4960,The anatomic site of the tumor,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,http://purl.obolibrary.org/obo/NCIT_C4960
Tumor Location,spinal cord,Tumor_Location,spinal_cord,M_Meningioma_3,M_Meningioma_42,C157120,NCIT_C6935,The anatomic site of the tumor,A meningioma that arises from the spinal cord meninges.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,http://purl.obolibrary.org/obo/NCIT_C6935
Tumor Location,falcine/falx cerebri,Tumor_Location,falcine_falx_cerebri,M_Meningioma_3,M_Meningioma_43,C157120,C5267,The anatomic site of the tumor,A meningioma that affects the falx cerebri.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5267
Tumor Location,optic nerve sheath,Tumor_Location,optic_nerve_sheath,M_Meningioma_3,M_Meningioma_44,C157120,NCIT_C4538,The anatomic site of the tumor.,A meningioma that arises from the sheath of the optic nerve.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157120,http://purl.obolibrary.org/obo/NCIT_C4538
MRI Features,peri-tumoral edema,MRI_Features,peri_tumoral_edema,M_Meningioma_5,M_Meningioma_45,C16809 AND C73619,C121674,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",An intracranial edema that develops around a tumor in the meninges or brain.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C121674
MRI Features,initial tumor volume cc,MRI_Features,initial_tumor_volume_cc,M_Meningioma_5,M_Meningioma_46,C16809 AND C73619,C122229,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",A rate unit equal to the number of micrograms per unit of volume equal to one liter per unit of time equal to one hour.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C122229
MRI Features,Hemorrhage,MRI_Features,Hemorrhage,M_Meningioma_5,M_Meningioma_47,C16809 AND C73619,NCIT_C26791,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",The flow of blood from a ruptured blood vessel.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,http://purl.obolibrary.org/obo/NCIT_C26791
MRI Features,Borders,MRI_Features,Borders,M_Meningioma_5,M_Meningioma_48,C16809 AND C73619,C80507,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",A boundary line or the area immediately inside the boundary.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C80507
MRI Features,intra-tumoral cysts,MRI_Features,intra_tumoral_cysts,M_Meningioma_5,M_Meningioma_49,C16809 AND C73619,C41454,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.","A finding consisting of multilocular cysts lined by fine septa containing fine flocculent eosinophilic material or, in some tissues, blood. The cysts are not lined by endothelial cells and do not compress the surrounding parenchyma. This does not include congenital polycystic change. (INHAND)",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C41454
MRI Features,necrosis,MRI_Features,necrosis,M_Meningioma_5,M_Meningioma_50,C16809 AND C73619,NCIT_C16897,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.","A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,http://purl.obolibrary.org/obo/NCIT_C16897
MRI Features,dural tail,MRI_Features,dural_tail,M_Meningioma_5,M_Meningioma_51,C16809 AND C73619,RID35182,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.","A tail of hyperenhanced dura mater is seen extending from a mass on MR images, suggesting a meningioma.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://radlex.org/RID/RID35182
MRI Features,involvement of surrounding tissue,MRI_Features,involvement_of_surrounding_tissue,M_Meningioma_5,M_Meningioma_52,C16809 AND C73619,C197539,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",Evidence of systemic involvement of connective tissue.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C197539
MRI Features,margins,MRI_Features,margins,M_Meningioma_5,M_Meningioma_53,C16809 AND C73619,C137709,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",Describes the morphologic appearance where a tumor meets the adjacent tissue.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137709
MRI Features,Tumor size(diameter),MRI_Features,Tumor_size_diameter,M_Meningioma_5,M_Meningioma_54,C16809 AND C73619,NCIT_C120284,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",The size of a tumor in its greatest dimension.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,http://purl.obolibrary.org/obo/NCIT_C120284
MRI Features,Pial invasion (pia mater invasion),MRI_Features,Pial_invasion,M_Meningioma_5,M_Meningioma_55,C16809 AND C73619,RID7101 AND RID39257,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",Tumor invasion of the pia mater of neuraxis,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/radlex/RID7101 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/radlex/RID39257
MRI Features,Shape of the lesion,MRI_Features,Shape_of_the_lesion,M_Meningioma_5,M_Meningioma_56,C16809 AND C73619,C37927,"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues; A prominent or identifiable aspect, region, or site of interest.",The spatial outline of an object as described by the configuration of straight or curved lines.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C73619,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37927
lateral right,medial sphenoid,lateral_right,medial_sphenoid,M_Meningioma_6,M_Meningioma_57,C160199 ,C25232 AND C12790,A finding indicating the tumor location is on the right side of the specimen.,Toward the middle or in a limb toward the median plane; The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160199,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25232 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12790
lateral right,lateral sphenoid,lateral_right,lateral_sphenoid,M_Meningioma_6,M_Meningioma_58,C160199 , C25230 AND C12790,A finding indicating the tumor location is on the right side of the specimen.,Situated at or extending to the side; The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160199,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25230 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12790
lateral right,cavernous sinus,lateral_right,cavernous_sinus,M_Meningioma_6,M_Meningioma_59,C160199 ,C5268,A finding indicating the tumor location is on the right side of the specimen.,A meningioma that affects the cavernous sinus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160199,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5268
lateral right,middle sphenoid,lateral_right,middle_sphenoid,M_Meningioma_6,M_Meningioma_60,C160199 ,C25569 AND C12790,A finding indicating the tumor location is on the right side of the specimen.,"An intermediate part or section, an area that is approximately central within some larger region; The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160199,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25569 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12790
lateral right,carebro-potine angle CPA,lateral_right,carebro_potine_angle_CPA,M_Meningioma_6,M_Meningioma_61,C160199 ,C5300,A finding indicating the tumor location is on the right side of the specimen.,A meningioma that affects the cerebellopontine angle.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160199,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5300
lateral left,medial sphenoid,lateral_left,medial_sphenoid,M_Meningioma_7,M_Meningioma_57,C160200,C25232 AND C12790,A finding indicating the tumor location is on the left side of the specimen.,Toward the middle or in a limb toward the median plane; The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160200,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25232 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12790
lateral left,lateral sphenoid,lateral_left,lateral_sphenoid,M_Meningioma_7,M_Meningioma_58,C160200, C25230 AND C12790,A finding indicating the tumor location is on the left side of the specimen.,Situated at or extending to the side; The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160200,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25230 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12790
lateral left,carebro-pontine angle CPA,lateral_left,carebro_pontine_angle_CPA,M_Meningioma_7,M_Meningioma_62,C160200,C5300,A finding indicating the tumor location is on the left side of the specimen.,A meningioma that affects the cerebellopontine angle,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160200,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5300
lateral left,cavernous sinus,lateral_left,cavernous_sinus,M_Meningioma_7,M_Meningioma_59,C160200,C5268,A finding indicating the tumor location is on the left side of the specimen.,A meningioma that affects the cavernous sinus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160200,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5268
lateral left,middle sphenoid,lateral_left,middle_sphenoid,M_Meningioma_7,M_Meningioma_60,C160200,,A finding indicating the tumor location is on the left side of the specimen.,,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160200,
description of lesion who CNS 5,prominent nucleoli,description_of_lesion_who_CNS_5,prominent_nucleoli,M_Meningioma_8,M_Meningioma_63,C166231,NCIT:C96634,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","A conspicuous nucleolus within the nucleus of a cell, often associated with increased ribosomal RNA synthesis and frequently observed in neoplastic cells.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C96634
description of lesion who CNS 5,cellularity,description_of_lesion_who_CNS_5,cellularity,M_Meningioma_8,M_Meningioma_64,C166231,C37923,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","The degree, quality, or condition of cells that are present.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37923
description of lesion who CNS 5,brain invasion,description_of_lesion_who_CNS_5,brain_invasion,M_Meningioma_8,M_Meningioma_65,C166231,C12439 AND C75004,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning; The movement of one cell type into an area normally occupied by a different cell type.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12439 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C75004
description of lesion who CNS 5,mitotic activity,description_of_lesion_who_CNS_5,mitotic_activity,M_Meningioma_8,M_Meningioma_66,C166231,C35959,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C35959
description of lesion who CNS 5,sheeting,description_of_lesion_who_CNS_5,sheeting,M_Meningioma_8,M_Meningioma_67,C166231,C42587,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",Sheet-Like Growth Pattern; loss of whorled or fascicular growth patterns,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C42587 AND https://pmc.ncbi.nlm.nih.gov/articles/PMC7354078/
description of lesion who CNS 5,necrosis,description_of_lesion_who_CNS_5,necrosis,M_Meningioma_8,M_Meningioma_50,C166231,NCIT_C16897,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,http://purl.obolibrary.org/obo/NCIT_C16897
description of lesion who CNS 5,nuclear cytoplasmic ratio,description_of_lesion_who_CNS_5,nuclear_cytoplasmic_ratio,M_Meningioma_8,M_Meningioma_68,C166231,,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",the ratio of the cross-sectional area of the nucleus divided by that of cytoplasm,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://www.spiedigitallibrary.org/journals/journal-of-biomedical-optics/volume-24/issue-10/106502/Determination-of-cell-nucleus-to-cytoplasmic-ratio-using-imaging-flow/10.1117/1.JBO.24.10.106502.full
description of lesion who CNS 5,psammomatous calcification,description_of_lesion_who_CNS_5,psammomatous_calcification,M_Meningioma_8,M_Meningioma_69,C166231,C27709,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",A calcified structure found in some benign (not cancer) or malignant (cancer) tumor cells. Psammoma bodies look like hardened concentric rings when viewed under a microscope. They can be a sign of chronic inflammation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C27709
Patient investigations,MRI,Patient_investigations,MRI,M_Meningioma_9,M_Meningioma_70,NCIT_C142430,C16809,"Any experiment that involves a test article and one or more human subjects, and must either meet the requirements for prior submission to the FDA or the results of which are to be submitted to or inspected by the FDA later as part of an application for a research or marketing permit.","A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C142430,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809
Patient investigations,CT scan,Patient_investigations,CT_scan,M_Meningioma_9,M_Meningioma_71,NCIT_C142430,NCIT_C17204,"Any experiment that involves a test article and one or more human subjects, and must either meet the requirements for prior submission to the FDA or the results of which are to be submitted to or inspected by the FDA later as part of an application for a research or marketing permit.",A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C142430,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C17204
Ionizing radiation exposure,No,Ionizing_radiation_exposure,No,M_Meningioma_10,M_Meningioma_72,C17052,C110959,"A type of radiation made (or given off) by x-ray procedures, radioactive substances, rays that enter the Earth's atmosphere from outer space, and other sources. At high doses, ionizing radiation increases chemical activity inside cells and can lead to health risks, including cancer.",Indicates that no answer was given,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17052,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Ionizing radiation exposure,yes,Ionizing_radiation_exposure,yes,M_Meningioma_10,M_Meningioma_73,C17052,C49488,"A type of radiation made (or given off) by x-ray procedures, radioactive substances, rays that enter the Earth's atmosphere from outer space, and other sources. At high doses, ionizing radiation increases chemical activity inside cells and can lead to health risks, including cancer.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17052,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
other disease,No,other_disease,No,M_Meningioma_11,M_Meningioma_72,C161320,C110959,Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.,Indicates that no answer was given,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C161320,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
other disease,Specify Drug,other_disease,Specify_Drug,M_Meningioma_11,M_Meningioma_74,C161320,C459,Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C161320,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
other disease,yes,other_disease,yes,M_Meningioma_11,M_Meningioma_73,C161320,C49488,Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C161320,
other disease,Duration,other_disease,Duration,M_Meningioma_11,M_Meningioma_75,C161320,C25330,Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.,The length of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C161320,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
other disease,under medication,other_disease,under_medication,M_Meningioma_11,M_Meningioma_76,C161320,C459,Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C161320,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
meningismus,No,meningismus,No,M_Meningioma_12,M_Meningioma_72,C79694,C110959,"A condition marked by headache, fever, and a stiff neck, which is caused when the meninges (three thin layers of tissue that cover and protect the brain and spinal cord) become irritated. Meningeal syndrome may be caused by blood, cancer cells, or substances from the breakdown of cancer cells that get into the cerebrospinal fluid (CSF). It may also be caused by infection with a bacterium, virus, or fungus.",Indicates that no answer was given,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C79694,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
meningismus,yes,meningismus,yes,M_Meningioma_12,M_Meningioma_73,C79694,C49488,"A condition marked by headache, fever, and a stiff neck, which is caused when the meninges (three thin layers of tissue that cover and protect the brain and spinal cord) become irritated. Meningeal syndrome may be caused by blood, cancer cells, or substances from the breakdown of cancer cells that get into the cerebrospinal fluid (CSF). It may also be caused by infection with a bacterium, virus, or fungus.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C79694,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
meningismus,Duration,meningismus,Duration,M_Meningioma_12,M_Meningioma_75,C79694,C25330,"A condition marked by headache, fever, and a stiff neck, which is caused when the meninges (three thin layers of tissue that cover and protect the brain and spinal cord) become irritated. Meningeal syndrome may be caused by blood, cancer cells, or substances from the breakdown of cancer cells that get into the cerebrospinal fluid (CSF). It may also be caused by infection with a bacterium, virus, or fungus.",The length of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C79694,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
hypertension,No,hypertension,No,M_Meningioma_13,M_Meningioma_72,C3117,C110959,"A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.",Indicates that no answer was given,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3117,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
hypertension,yes,hypertension,yes,M_Meningioma_13,M_Meningioma_73,C3117,C49488,"A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3117,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
hypertension,Duration,hypertension,Duration,M_Meningioma_13,M_Meningioma_75,C3117,C25330,"A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.",The length of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3117,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
hypertension,Specify drug,hypertension,Specify_drug,M_Meningioma_13,M_Meningioma_77,C3117,C459,"A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.",Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3117,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
hypertension,under medication,hypertension,under_medication,M_Meningioma_13,M_Meningioma_76,C3117,C459,"A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.",Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3117,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Headache,No,Headache,No,M_Meningioma_14,M_Meningioma_72,C34661,C49487,Pain in any region of the head.,The non-affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C34661,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49487
Headache,yes,Headache,yes,M_Meningioma_14,M_Meningioma_73,C34661,C49488,Pain in any region of the head.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C34661,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Headache,Duration,Headache,Duration,M_Meningioma_14,M_Meningioma_75,C34661,C25330,Pain in any region of the head.,The length of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C34661,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Asymptomatic,No,Asymptomatic,No,M_Meningioma_15,M_Meningioma_72,C3833,C110959,Having no signs or symptoms of disease.,"Attribution
Indicates that no answer was given.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3833,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Asymptomatic,yes,Asymptomatic,yes,M_Meningioma_15,M_Meningioma_73,C3833,C49488,Having no signs or symptoms of disease.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3833,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Asymptomatic,Duration,Asymptomatic,Duration,M_Meningioma_15,M_Meningioma_75,C3833,C25330,Having no signs or symptoms of disease.,"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3833,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
hypercholesterolemia,No,hypercholesterolemia,No,M_Meningioma_16,M_Meningioma_72,C37967,C110959,A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.,"Attribution
Indicates that no answer was given",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37967,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
hypercholesterolemia,yes,hypercholesterolemia,yes,M_Meningioma_16,M_Meningioma_73,C37967,C49488,A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37967,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
hypercholesterolemia,specify durg,hypercholesterolemia,specify_durg,M_Meningioma_16,M_Meningioma_78,C37967,C459,A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37967,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
hypercholesterolemia,Duration,hypercholesterolemia,Duration,M_Meningioma_16,M_Meningioma_75,C37967,C25330,A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.,"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37967,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
hypercholesterolemia,under medication,hypercholesterolemia,under_medication,M_Meningioma_16,M_Meningioma_76,C37967,C459,A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37967,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Seizures,No,Seizures,No,M_Meningioma_17,M_Meningioma_72,C2962,C110959,"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","Attribution
Indicates that no answer was given",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2962,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Seizures,yes,Seizures,yes,M_Meningioma_17,M_Meningioma_73,C2962,C49488,"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2962,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Seizures,Duration,Seizures,Duration,M_Meningioma_17,M_Meningioma_75,C2962,C25330,"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2962,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
cerebellar features,No,cerebellar_features,No,M_Meningioma_18,M_Meningioma_72,C12445,C110959,"Brain structure derived from the anterior hindbrain, and perhaps including posterior midbrain. The cerebellum plays a role in somatic motor function, the control of muscle tone, and balance.","Attribution
Indicates that no answer was given",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12445,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
cerebellar features,yes,cerebellar_features,yes,M_Meningioma_18,M_Meningioma_73,C12445,C49488,"Brain structure derived from the anterior hindbrain, and perhaps including posterior midbrain. The cerebellum plays a role in somatic motor function, the control of muscle tone, and balance.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12445,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
cerebellar features,Duration,cerebellar_features,Duration,M_Meningioma_18,M_Meningioma_75,C12445,C25330,"Brain structure derived from the anterior hindbrain, and perhaps including posterior midbrain. The cerebellum plays a role in somatic motor function, the control of muscle tone, and balance.","The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12445,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Diabetes mellitus,No,Diabetes_mellitus,No,M_Meningioma_19,M_Meningioma_72,C2985,C110959,A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.,"Attribution
Indicates that no answer was given",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Diabetes mellitus,yes,Diabetes_mellitus,yes,M_Meningioma_19,M_Meningioma_73,C2985,C49488,A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Diabetes mellitus,Duration,Diabetes_mellitus,Duration,M_Meningioma_19,M_Meningioma_75,C2985,C25330,A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.,"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Diabetes mellitus,specify drug,Diabetes_mellitus,specify_drug,M_Meningioma_19,M_Meningioma_79,C2985,C459,A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Diabetes mellitus,under medication,Diabetes_mellitus,under_medication,M_Meningioma_19,M_Meningioma_76,C2985,C459,A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Hypothyroidism,No,Hypothyroidism,No,M_Meningioma_20,M_Meningioma_72,C26800,C110959,A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.,"Attribution
Indicates that no answer was given",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26800,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Hypothyroidism,yes,Hypothyroidism,yes,M_Meningioma_20,M_Meningioma_73,C26800,C49488,A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.,The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26800,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Hypothyroidism,specify durg,Hypothyroidism,specify_durg,M_Meningioma_20,M_Meningioma_78,C26800,C459,A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26800,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Hypothyroidism,Duration,Hypothyroidism,Duration,M_Meningioma_20,M_Meningioma_75,C26800,C25330,A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.,"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26800,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Hypothyroidism,under medication,Hypothyroidism,under_medication,M_Meningioma_20,M_Meningioma_76,C26800,C459,A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.,Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26800,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Renal insufficiency,No,Renal_insufficiency,No,M_Meningioma_21,M_Meningioma_72,C4376,C110959,"A condition in which the kidneys stop working and are not able to remove waste and extra water from the blood or keep body chemicals in balance. Acute or severe renal failure happens suddenly (for example, after an injury) and may be treated and cured. Chronic renal failure develops over many years, may be caused by conditions like high blood pressure or diabetes, and cannot be cured. Chronic renal failure may lead to total and long-lasting renal failure, called end-stage renal disease (ESRD). A person in ESRD needs dialysis (the process of cleaning the blood by passing it through a membrane or filter) or a kidney transplant.","Attribution
Indicates that no answer was give",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4376,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Renal insufficiency,yes,Renal_insufficiency,yes,M_Meningioma_21,M_Meningioma_73,C4376,C49488,"A condition in which the kidneys stop working and are not able to remove waste and extra water from the blood or keep body chemicals in balance. Acute or severe renal failure happens suddenly (for example, after an injury) and may be treated and cured. Chronic renal failure develops over many years, may be caused by conditions like high blood pressure or diabetes, and cannot be cured. Chronic renal failure may lead to total and long-lasting renal failure, called end-stage renal disease (ESRD). A person in ESRD needs dialysis (the process of cleaning the blood by passing it through a membrane or filter) or a kidney transplant.",The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4376,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Renal insufficiency,Duration,Renal_insufficiency,Duration,M_Meningioma_21,M_Meningioma_75,C4376,C25330,"A condition in which the kidneys stop working and are not able to remove waste and extra water from the blood or keep body chemicals in balance. Acute or severe renal failure happens suddenly (for example, after an injury) and may be treated and cured. Chronic renal failure develops over many years, may be caused by conditions like high blood pressure or diabetes, and cannot be cured. Chronic renal failure may lead to total and long-lasting renal failure, called end-stage renal disease (ESRD). A person in ESRD needs dialysis (the process of cleaning the blood by passing it through a membrane or filter) or a kidney transplant.","The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4376,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Renal insufficiency,specify drug,Renal_insufficiency,specify_drug,M_Meningioma_21,M_Meningioma_79,C4376,C459,"A condition in which the kidneys stop working and are not able to remove waste and extra water from the blood or keep body chemicals in balance. Acute or severe renal failure happens suddenly (for example, after an injury) and may be treated and cured. Chronic renal failure develops over many years, may be caused by conditions like high blood pressure or diabetes, and cannot be cured. Chronic renal failure may lead to total and long-lasting renal failure, called end-stage renal disease (ESRD). A person in ESRD needs dialysis (the process of cleaning the blood by passing it through a membrane or filter) or a kidney transplant.",Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4376,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Renal insufficiency,under medication,Renal_insufficiency,under_medication,M_Meningioma_21,M_Meningioma_76,C4376,C459,"A condition in which the kidneys stop working and are not able to remove waste and extra water from the blood or keep body chemicals in balance. Acute or severe renal failure happens suddenly (for example, after an injury) and may be treated and cured. Chronic renal failure develops over many years, may be caused by conditions like high blood pressure or diabetes, and cannot be cured. Chronic renal failure may lead to total and long-lasting renal failure, called end-stage renal disease (ESRD). A person in ESRD needs dialysis (the process of cleaning the blood by passing it through a membrane or filter) or a kidney transplant.",Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4376,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Pulmonary disease,No,Pulmonary_disease,No,M_Meningioma_22,M_Meningioma_72,C3198,C110959,"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","Attribution
Indicates that no answer was give",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3198,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Pulmonary disease,yes,Pulmonary_disease,yes,M_Meningioma_22,M_Meningioma_73,C3198,C49488,"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).",The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3198,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Pulmonary disease,Duration,Pulmonary_disease,Duration,M_Meningioma_22,M_Meningioma_75,C3198,C25330,"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3198,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Pulmonary disease,specify drug,Pulmonary_disease,specify_drug,M_Meningioma_22,M_Meningioma_79,C3198,C459,"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).",Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3198,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Pulmonary disease,under medication,Pulmonary_disease,under_medication,M_Meningioma_22,M_Meningioma_76,C3198,C459,"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).",Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3198,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Coronary heart disease,No,Coronary_heart_disease,No,M_Meningioma_23,M_Meningioma_72,C26732,C110959,Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC),"Attribution
Indicates that no answer was give",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26732,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Coronary heart disease,yes,Coronary_heart_disease,yes,M_Meningioma_23,M_Meningioma_73,C26732,C49488,Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC),The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26732,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Coronary heart disease,Duration,Coronary_heart_disease,Duration,M_Meningioma_23,M_Meningioma_75,C26732,C25330,Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC),"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26732,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Coronary heart disease,specify drug,Coronary_heart_disease,specify_drug,M_Meningioma_23,M_Meningioma_79,C26732,C459,Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC),Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26732,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Coronary heart disease,under medication,Coronary_heart_disease,under_medication,M_Meningioma_23,M_Meningioma_76,C26732,C459,Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC),Name of medication being taken by patient.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26732,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
Loss of consciousness,No,Loss_of_consciousness,No,M_Meningioma_24,M_Meningioma_72,C50635,C110959,A level of awareness that can be described as consistently not responsive to stimuli.,"Attribution
Indicates that no answer was give",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50635,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Loss of consciousness,yes,Loss_of_consciousness,yes,M_Meningioma_24,M_Meningioma_73,C50635,C49488,A level of awareness that can be described as consistently not responsive to stimuli.,The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50635,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Loss of consciousness,Duration,Loss_of_consciousness,Duration,M_Meningioma_24,M_Meningioma_75,C50635,C25330,A level of awareness that can be described as consistently not responsive to stimuli.,"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50635,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Vertigo,No,Vertigo,No,M_Meningioma_25,M_Meningioma_72,C38057,C110959,A disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).,"Attribution
Indicates that no answer was give",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38057,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Vertigo,yes,Vertigo,yes,M_Meningioma_25,M_Meningioma_73,C38057,C49488,A disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).,The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38057,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Vertigo,Duration,Vertigo,Duration,M_Meningioma_25,M_Meningioma_75,C38057,C25330,A disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).,"The
 length of time during which something continues.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38057,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
carnial nerve deficits,No,carnial_nerve_deficits,No,M_Meningioma_26,M_Meningioma_72,C26733,C110959,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,"Attribution
Indicates that no answer was give",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
carnial nerve deficits,yes,carnial_nerve_deficits,yes,M_Meningioma_26,M_Meningioma_73,C26733,C49488,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
carnial nerve deficits,I,carnial_nerve_deficits,I,M_Meningioma_26,M_Meningioma_80,C26733,C27210,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,A disorder characterized by involvement of the olfactory nerve (first cranial nerve).,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C27210
carnial nerve deficits,IX,carnial_nerve_deficits,IX,M_Meningioma_26,M_Meningioma_81,C26733,C58441,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C58441
carnial nerve deficits,VII,carnial_nerve_deficits,VII,M_Meningioma_26,M_Meningioma_82,C26733,C55517,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,Life-threatening; disabling,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55517
carnial nerve deficits,VIII,carnial_nerve_deficits,VIII,M_Meningioma_26,M_Meningioma_83,C26733,C55520,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,"Asymptomatic, detected on exam/testing only",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55520
carnial nerve deficits,XII,carnial_nerve_deficits,XII,M_Meningioma_26,M_Meningioma_84,C26733,C55498,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,"Attribution
Symptomatic, interfering with ADL",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55498
carnial nerve deficits,VI,carnial_nerve_deficits,VI,M_Meningioma_26,M_Meningioma_85,C26733,C58445,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C58445
carnial nerve deficits,X,carnial_nerve_deficits,X,M_Meningioma_26,M_Meningioma_86,C26733,C55525,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55525
carnial nerve deficits,XI,carnial_nerve_deficits,XI,M_Meningioma_26,M_Meningioma_87,C26733,C58450,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C58450
carnial nerve deficits,IV,carnial_nerve_deficits,IV,M_Meningioma_26,M_Meningioma_88,C26733,C58439,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C58439
carnial nerve deficits,II,carnial_nerve_deficits,II,M_Meningioma_26,M_Meningioma_89,C26733,C55478,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,Mild cognitive disability; not interfering with work/school/life performance; specialized educational services/devices not indicated,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55478
carnial nerve deficits,III,carnial_nerve_deficits,III,M_Meningioma_26,M_Meningioma_90,C26733,C55486,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,Severe cognitive disability; significant impairment of work/school/life performance,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55486
carnial nerve deficits,V,carnial_nerve_deficits,V,M_Meningioma_26,M_Meningioma_91,C26733,C55501,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C55501
MRI machine,MRI machine type,MRI_machine,MRI_machine_type,M_Meningioma_27,M_Meningioma_92,C16809,C178920,"A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones.",The type of equipment used.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C178920
post operative follow up,follow up mri,post_operative_follow_up,follow_up_mri,M_Meningioma_28,M_Meningioma_93,C16033,C53579,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.",A report that comes some time after an initial study and report.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C53579
post operative follow up,Re do surgery,post_operative_follow_up,Re_do_surgery,M_Meningioma_28,M_Meningioma_94,C16033,C50830,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.",Repeat performance of a surgical procedure or intervention. (ACC),,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830
post operative follow up,in this post op MRI Residual disease,post_operative_follow_up,in_this_post_op_MRI_Residual_disease,M_Meningioma_28,M_Meningioma_95,C16033,C4809,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.","Cancer cells that remain after attempts to remove the cancer have been made. 
The persistence of tumor cells in the body following cancer treatment.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4809
post operative follow up,adjuvant RT,post_operative_follow_up,adjuvant_RT,M_Meningioma_28,M_Meningioma_96,C16033,C15675,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.","Another treatment used together with the primary treatment. Its purpose is to assist the primary treatment. 
Any therapy that is administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence subsequent to the main treatment plan",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C15675
post operative follow up,last of follow up date,post_operative_follow_up,last_of_follow_up_date,M_Meningioma_28,M_Meningioma_97,C16033,C164549,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends.",The date on which the temporally most recent follow-up took place.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164549
Molecular markers,Homozygous deletion of CDKN2A and /or CDKN2B,Molecular_markers,Homozygous_deletion_of_CDKN2A_and_or_CDKN2B,M_Meningioma_29,M_Meningioma_98,C16342,C185173,"A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.",A molecular abnormality referring to the loss of both copies of the CDKN2B gene.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16342,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C185173
MRI machine type,MRI GK GE 450W version 1.5T magnet,MRI_machine_type,MRI_GK_GE_450W_version_1_5T_magnet,M_Meningioma_30,M_Meningioma_99,C178920,C185866,The type of equipment used.,MRI that uses a magnet capable of producing a 1.5 tesla field strength.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C178920,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C185866
MRI machine type,NMR ingenia philips 3T magnet with 70 cm bore size,MRI_machine_type,NMR_ingenia_philips_3T_magnet_with_70_cm_bore_size,M_Meningioma_30,M_Meningioma_100,C178920,C19577,The type of equipment used.,Various NMR methods that can be used to determine 3D structures.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C178920,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C19577 AND https://www.documents.philips.com/assets/20170523/ba8a9ee081754b928b1aa77c016a093c.pdf
Histopathological details,tert promoter mutation,Histopathological_details,tert_promoter_mutation,M_Meningioma_31,M_Meningioma_101,C93427,C160585,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,A molecular abnormality indicating mutation in the promoter region of the TERT gene.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160585
Histopathological details,Histopathological diagnosis,Histopathological_details,Histopathological_diagnosis,M_Meningioma_31,M_Meningioma_102,C93427,C164406,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"The completed activity within the context of a given study that represents the results of a histopathology assessment. 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406
Histopathological details,Who Grade III,Histopathological_details,Who_Grade_III,M_Meningioma_31,M_Meningioma_103,C93427,C38938,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"A malignant meningioma with aggressive clinical course. It recurs in approximately 50-78% of the cases. This category includes the anaplastic (malignant) meningioma, papillary meningioma, and rhabdoid meningioma.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38938
Histopathological details,Evaluation of tumor tissue,Histopathological_details,Evaluation_of_tumor_tissue,M_Meningioma_31,M_Meningioma_104,C93427,C125006,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,An appraisal by a pathologist that is based on microscopic and macroscopic structural and functional changes that result from disease processes.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C125006
Histopathological details,Who Grade I,Histopathological_details,Who_Grade_I,M_Meningioma_31,M_Meningioma_105,C93427,C38936,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"A benign neoplasm of the meninges. 
A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38936
Histopathological details,WHO Grade II,Histopathological_details,WHO_Grade_II,M_Meningioma_31,M_Meningioma_106,C93427,C38937,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"An atypical meningioma which may recur in approximately 29-40% of the cases. This category includes the atypical meningioma, chordoid meningioma, and clear cell meningioma.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38937
Histopathological details,imaging equipment utilized,Histopathological_details,imaging_equipment_utilized,M_Meningioma_31,M_Meningioma_107,C93427,C178920,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,The type of equipment used.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C178920
Histopathological details,Molecular markers,Histopathological_details,Molecular_markers,M_Meningioma_31,M_Meningioma_108,C93427,C16342,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16342
Histopathological details,Quality assessment of Slide assessment,Histopathological_details,Quality_assessment_of_Slide_assessment,M_Meningioma_31,M_Meningioma_109,C93427,C162621,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"Tissue Source Sites (TSS) will perform a QC review of tumor biospecimens by review of slides from corresponding FFPE QC blocks. For each tumor segment, an H&E-stained slide is to be prepared and reviewed by the TSS pathologist to confirm accuracy of tissue diagnosis and tumor composition.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162621
Histopathological details,description of lesion who CNS 5,Histopathological_details,description_of_lesion_who_CNS_5,M_Meningioma_31,M_Meningioma_110,C93427,,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,
Histopathological details,immuno-histochemical IHC Markers,Histopathological_details,immuno_histochemical_IHC_Markers,M_Meningioma_31,M_Meningioma_111,C93427,C162597,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,The use of immunohistochemical methods to detect the expression of proteins in a sample.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162597
family history,sister,family_history,sister,M_Meningioma_32,M_Meningioma_112,C17726,C25680,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,"Attribution
A female sibling.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25680
family history,yes,family_history,yes,M_Meningioma_32,M_Meningioma_73,C17726,C49488,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,"Attribution
The affirmative response to a question.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
family history,brother,family_history,brother,M_Meningioma_32,M_Meningioma_113,C17726,C25289,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,A male sibling.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25289
family history,no,family_history,no,M_Meningioma_32,M_Meningioma_114,C17726,C110959,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,"Attribution
Indicates that no answer was given.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
family history,mother,family_history,mother,M_Meningioma_32,M_Meningioma_115,C17726,C25189,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,"Attribution
A female parent",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25189
family history,others,family_history,others,M_Meningioma_32,M_Meningioma_116,C17726,C168369,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,An indication that the primary reason for a patient visit to a healthcare provider is other than those listed.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168369
family history,disease,family_history,disease,M_Meningioma_32,M_Meningioma_117,C17726,C2991,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991
family history,father,family_history,father,M_Meningioma_32,M_Meningioma_118,C17726,C25174,A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions.,A male parent,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17726,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25174
Number of lesion,Single,Number_of_lesion,Single,M_Meningioma_33,M_Meningioma_119,C174277,C48440,The number of lesions observed.,"Not accompanied by another or others; exclusive of anyone or anything else. NCI 
One.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C174277,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48440
Number of lesion,Multiple,Number_of_lesion,Multiple,M_Meningioma_33,M_Meningioma_120,C174277,C17648,The number of lesions observed.,"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold. 
More than one.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C174277,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17648
Volume of tissue,inadequate,Volume_of_tissue,inadequate,M_Meningioma_34,M_Meningioma_121,C95001,C69177,A user-selected volume within a 3D image. The choice is guided by knowledge that activities concentrations for the voxels within the boundary contour of this region will be used in quantifying it.,Not meeting a quantitative or qualitative measure necessary for a requirement.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C95001,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69177
Volume of tissue,low,Volume_of_tissue,low,M_Meningioma_34,M_Meningioma_122,C95001,C54722,A user-selected volume within a 3D image. The choice is guided by knowledge that activities concentrations for the voxels within the boundary contour of this region will be used in quantifying it.,,"A minimum level or position or degree; less than normal in degree, intensity or amount.",,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C95001,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
Volume of tissue,moderate,Volume_of_tissue,moderate,M_Meningioma_34,M_Meningioma_123,C95001,C61376,A user-selected volume within a 3D image. The choice is guided by knowledge that activities concentrations for the voxels within the boundary contour of this region will be used in quantifying it.,"Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C95001,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
Volume of tissue,high,Volume_of_tissue,high,M_Meningioma_34,M_Meningioma_124,C95001,C25227,A user-selected volume within a 3D image. The choice is guided by knowledge that activities concentrations for the voxels within the boundary contour of this region will be used in quantifying it.,An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C95001,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
identification of invasive tumor front,inadequate,identification_of_invasive_tumor_front,inadequate,M_Meningioma_35,M_Meningioma_121,C137710,C69177,Describes a tumor border that is invading the adjacent tissue.,Not meeting a quantitative or qualitative measure necessary for a requirement.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137710,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69177
identification of invasive tumor front,low,identification_of_invasive_tumor_front,low,M_Meningioma_35,M_Meningioma_122,C137710,C54722,Describes a tumor border that is invading the adjacent tissue.,"A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137710,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
identification of invasive tumor front,moderate,identification_of_invasive_tumor_front,moderate,M_Meningioma_35,M_Meningioma_123,C137710,C61376,Describes a tumor border that is invading the adjacent tissue.,"Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137710,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
identification of invasive tumor front,high,identification_of_invasive_tumor_front,high,M_Meningioma_35,M_Meningioma_124,C137710,C25227,Describes a tumor border that is invading the adjacent tissue.,An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137710,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
Evaluation of dura,inadequate,Evaluation_of_dura,inadequate,M_Meningioma_36,M_Meningioma_121,C25214 AND C32488,C69177,"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.The outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord.",Not meeting a quantitative or qualitative measure necessary for a requirement.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C32488,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69177
Evaluation of dura,low,Evaluation_of_dura,low,M_Meningioma_36,M_Meningioma_122,C25214 AND C32488,C54722,"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.The outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C32488,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
Evaluation of dura,moderate,Evaluation_of_dura,moderate,M_Meningioma_36,M_Meningioma_123,C25214 AND C32488,C61376,"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.The outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C32488,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
Evaluation of dura,high,Evaluation_of_dura,high,M_Meningioma_36,M_Meningioma_124,C25214 AND C32488,C25227,"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.The outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C32488,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
identification of lesional area,inadequate,identification_of_lesional_area,inadequate,M_Meningioma_37,M_Meningioma_121,C94189,C69177,An indication that a lesion has been located and characterized.,Not meeting a quantitative or qualitative measure necessary for a requirement.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C94189,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69177
identification of lesional area,low,identification_of_lesional_area,low,M_Meningioma_37,M_Meningioma_122,C94189,C54722,An indication that a lesion has been located and characterized.,"A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C94189,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
identification of lesional area,moderate,identification_of_lesional_area,moderate,M_Meningioma_37,M_Meningioma_123,C94189,C61376,An indication that a lesion has been located and characterized.,"Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C94189,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
identification of lesional area,high,identification_of_lesional_area,high,M_Meningioma_37,M_Meningioma_124,C94189,C25227,An indication that a lesion has been located and characterized.,An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C94189,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
Evaluation of bone,inadequate,Evaluation_of_bone,inadequate,M_Meningioma_38,M_Meningioma_121,C12366 AND C25214,C69177,"Calcified connective tissue that forms the skeletal components of the body.Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.",Not meeting a quantitative or qualitative measure necessary for a requirement.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69177
Evaluation of bone,Low,Evaluation_of_bone,Low,M_Meningioma_38,M_Meningioma_125,C12366 AND C25214,C54722,"Calcified connective tissue that forms the skeletal components of the body.Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
Evaluation of bone,moderate,Evaluation_of_bone,moderate,M_Meningioma_38,M_Meningioma_123,C12366 AND C25214,C61376,"Calcified connective tissue that forms the skeletal components of the body.Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
Evaluation of bone,high,Evaluation_of_bone,high,M_Meningioma_38,M_Meningioma_124,C12366 AND C25214,C25227,"Calcified connective tissue that forms the skeletal components of the body.Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
morphology,inadequate,morphology,inadequate,M_Meningioma_39,M_Meningioma_121,C17943,C69177,"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same. In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.",Not meeting a quantitative or qualitative measure necessary for a requirement.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17943,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69177
morphology,low,morphology,low,M_Meningioma_39,M_Meningioma_122,C17943,C54722,"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same. In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17943,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
morphology,moderate,morphology,moderate,M_Meningioma_39,M_Meningioma_123,C17943,C61376,"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same. In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17943,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
morphology,high,morphology,high,M_Meningioma_39,M_Meningioma_124,C17943,C25227,"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same. In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17943,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
presenting symptoms and signs,motor weakness,presenting_symptoms_and_signs,motor_weakness,M_Meningioma_40,M_Meningioma_126,C168433,C50658,Symptoms and signs present with the chief complaint.,A reduction in the strength of one or more muscles.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433
presenting symptoms and signs,meningismus,presenting_symptoms_and_signs,meningismus,M_Meningioma_40,M_Meningioma_127,C168433,C79694,Symptoms and signs present with the chief complaint.,"A condition marked by headache, fever, and a stiff neck, which is caused when the meninges (three thin layers of tissue that cover and protect the brain and spinal cord) become irritated. Meningeal syndrome may be caused by blood, cancer cells, or substances from the breakdown of cancer cells that get into the cerebrospinal fluid (CSF). It may also be caused by infection with a bacterium, virus, or fungus.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C79694
presenting symptoms and signs,Headache,presenting_symptoms_and_signs,Headache,M_Meningioma_40,M_Meningioma_128,C168433,C34661,Symptoms and signs present with the chief complaint.,Pain in any region of the head.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C34661
presenting symptoms and signs,sensory loss,presenting_symptoms_and_signs,sensory_loss,M_Meningioma_40,M_Meningioma_129,C168433,C182234,Symptoms and signs present with the chief complaint.,"Attribution
Any loss of sensation.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182234
presenting symptoms and signs,Asymptomatic,presenting_symptoms_and_signs,Asymptomatic,M_Meningioma_40,M_Meningioma_130,C168433,C3833,Symptoms and signs present with the chief complaint.,Having no signs or symptoms of disease,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3833
presenting symptoms and signs,Seizures,presenting_symptoms_and_signs,Seizures,M_Meningioma_40,M_Meningioma_131,C168433,SNOMED CT - 91175000,Symptoms and signs present with the chief complaint.,A transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433
presenting symptoms and signs,cerebellar features,presenting_symptoms_and_signs,cerebellar_features,M_Meningioma_40,M_Meningioma_132,C168433,,Symptoms and signs present with the chief complaint.,"Lesions of the cerebellum produce neurological signs that are easy to recognize and have been shown to have excellent inter-rater reliability.[1] These signs evolve secondary to lesions in the vestibulocerebellar, vestibulospinal, and cerebellar ocular motor tracts. However, many signs, such as gait ataxia and nystagmus, may present in non-cerebellar lesions. A detailed neurological exam and a good history assist in accurate localization.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://www.ncbi.nlm.nih.gov/books/NBK556080/
presenting symptoms and signs,other specify,presenting_symptoms_and_signs,other_specify,M_Meningioma_40,M_Meningioma_133,C168433,C157106,Symptoms and signs present with the chief complaint.,A directive to indicate a response not listed.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157106
presenting symptoms and signs,preoperative KPS score,presenting_symptoms_and_signs,preoperative_KPS_score,M_Meningioma_40,M_Meningioma_134,C168433,C100417,Symptoms and signs present with the chief complaint.,Karnofsky Performance Status Scale (KPS Scale) Karnofsky Performance Status.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C100417
presenting symptoms and signs,Loss of consciousness,presenting_symptoms_and_signs,Loss_of_consciousness,M_Meningioma_40,M_Meningioma_135,C168433,C50635,Symptoms and signs present with the chief complaint.,A level of awareness that can be described as consistently not responsive to stimuli.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50635
presenting symptoms and signs,Vertigo,presenting_symptoms_and_signs,Vertigo,M_Meningioma_40,M_Meningioma_136,C168433,C38057,Symptoms and signs present with the chief complaint.,A disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C38057
presenting symptoms and signs,carnial nerve deficits,presenting_symptoms_and_signs,carnial_nerve_deficits,M_Meningioma_40,M_Meningioma_137,C168433,C26733,Symptoms and signs present with the chief complaint.,A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168433,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26733
peri-tumoral edema,present,peri_tumoral_edema,present,M_Meningioma_41,M_Meningioma_138,C121674,C25626,An intracranial edema that develops around a tumor in the meninges or brain.,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C121674,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
peri-tumoral edema,absent,peri_tumoral_edema,absent,M_Meningioma_41,M_Meningioma_139,C121674,C48190,An intracranial edema that develops around a tumor in the meninges or brain.,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C121674,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
prominent nucleoli,present,prominent_nucleoli,present,M_Meningioma_42,M_Meningioma_138,C49026,C25626,Inclusion-Like Nucleoli,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49026,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
prominent nucleoli,absent,prominent_nucleoli,absent,M_Meningioma_42,M_Meningioma_139,C49026,C48190,Inclusion-Like Nucleoli,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49026,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
Homozygous deletion of CDKN2A and /or CDKN2B,present,Homozygous_deletion_of_CDKN2A_and_or_CDKN2B,present,M_Meningioma_43,M_Meningioma_138,C185173,C25626,A molecular abnormality referring to the loss of both copies of the CDKN2B gene.,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C185173,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
Homozygous deletion of CDKN2A and /or CDKN2B,not done,Homozygous_deletion_of_CDKN2A_and_or_CDKN2B,not_done,M_Meningioma_43,M_Meningioma_140,C185173,C49484,A molecular abnormality referring to the loss of both copies of the CDKN2B gene.,"Indicates a task, process or examination that has either not been initiated or completed. (NCI)",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C185173,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49484
Homozygous deletion of CDKN2A and /or CDKN2B,absent,Homozygous_deletion_of_CDKN2A_and_or_CDKN2B,absent,M_Meningioma_43,M_Meningioma_139,C185173,C48190,A molecular abnormality referring to the loss of both copies of the CDKN2B gene.,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C185173,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
tert promoter mutation,present,tert_promoter_mutation,present,M_Meningioma_44,M_Meningioma_138,C160585,C25626,A molecular abnormality indicating mutation in the promoter region of the TERT gene.,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160585,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
tert promoter mutation,not done,tert_promoter_mutation,not_done,M_Meningioma_44,M_Meningioma_140,C160585,C49484,A molecular abnormality indicating mutation in the promoter region of the TERT gene.,"Indicates a task, process or examination that has either not been initiated or completed. (NCI)",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160585,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49484
tert promoter mutation,absent,tert_promoter_mutation,absent,M_Meningioma_44,M_Meningioma_139,C160585,C48190,A molecular abnormality indicating mutation in the promoter region of the TERT gene.,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160585,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
brain invasion,present,brain_invasion,present,M_Meningioma_45,M_Meningioma_138,C20625,C25626,"The local spread of tumor cells of a malignant neoplasm through infiltration or destruction of adjacent tissue; for epithelial neoplasms, invasion signifies infiltration beneath the epithelial basement membrane.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C20625,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
brain invasion,brain parenchyma not included in the section,brain_invasion,brain_parenchyma_not_included_in_the_section,M_Meningioma_45,M_Meningioma_141,C20625,C12439 AND C48661,"The local spread of tumor cells of a malignant neoplasm through infiltration or destruction of adjacent tissue; for epithelial neoplasms, invasion signifies infiltration beneath the epithelial basement membrane.","An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning; The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C20625,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12439 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48661
brain invasion,adherent brain parenchyma but no invasion,brain_invasion,adherent_brain_parenchyma_but_no_invasion,M_Meningioma_45,M_Meningioma_142,C20625,C49487 AND C12439 AND C75004,"The local spread of tumor cells of a malignant neoplasm through infiltration or destruction of adjacent tissue; for epithelial neoplasms, invasion signifies infiltration beneath the epithelial basement membrane.",The non-affirmative response to a question; An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning; The movement of one cell type into an area normally occupied by a different cell type.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C20625,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49487 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12439 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C75004
brain invasion,absent,brain_invasion,absent,M_Meningioma_45,M_Meningioma_139,C20625,C48190,"The local spread of tumor cells of a malignant neoplasm through infiltration or destruction of adjacent tissue; for epithelial neoplasms, invasion signifies infiltration beneath the epithelial basement membrane.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C20625,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
Hemorrhage,present,Hemorrhage,present,M_Meningioma_46,M_Meningioma_138,C26791,C25626,"In medicine, loss of blood from damaged blood vessels. A hemorrhage may be internal or external, and usually involves a lot of bleeding in a short time.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26791,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
Hemorrhage,absent,Hemorrhage,absent,M_Meningioma_46,M_Meningioma_139,C26791,C48190,"In medicine, loss of blood from damaged blood vessels. A hemorrhage may be internal or external, and usually involves a lot of bleeding in a short time.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26791,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
mitotic activity,present,mitotic_activity,present,M_Meningioma_47,M_Meningioma_138,C35959,C25626,Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C35959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
mitotic activity,absent,mitotic_activity,absent,M_Meningioma_47,M_Meningioma_139,C35959,C48190,Having to do with the presence of dividing (proliferating) cells. Cancerous tissue generally has more mitotic activity than normal tissues.,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C35959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
intra-tumoral cysts,present,intra_tumoral_cysts,present,M_Meningioma_48,M_Meningioma_138,C41454,C25626,"A finding consisting of multilocular cysts lined by fine septa containing fine flocculent eosinophilic material or, in some tissues, blood. The cysts are not lined by endothelial cells and do not compress the surrounding parenchyma. This does not include congenital polycystic change. 
A microscopic finding indicating the formation of cystic structures in a tissue sample.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C41454,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
intra-tumoral cysts,absent,intra_tumoral_cysts,absent,M_Meningioma_48,M_Meningioma_139,C41454,C48190,"A finding consisting of multilocular cysts lined by fine septa containing fine flocculent eosinophilic material or, in some tissues, blood. The cysts are not lined by endothelial cells and do not compress the surrounding parenchyma. This does not include congenital polycystic change. 
A microscopic finding indicating the formation of cystic structures in a tissue sample.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C41454,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
in this post op MRI Residual disease,present,in_this_post_op_MRI_Residual_disease,present,M_Meningioma_49,M_Meningioma_138,C4809,C25626,"Cancer cells that remain after attempts to remove the cancer have been made. NCI-GLOSS 
The persistence of tumor cells in the body following cancer treatment.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
in this post op MRI Residual disease,absent,in_this_post_op_MRI_Residual_disease,absent,M_Meningioma_49,M_Meningioma_139,C4809,C48190,"Cancer cells that remain after attempts to remove the cancer have been made. NCI-GLOSS 
The persistence of tumor cells in the body following cancer treatment.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
Flair Changes,present,Flair_Changes,present,M_Meningioma_50,M_Meningioma_138,C82392 AND C25446,C25626,"A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest. The act of alteration or modification; changed or altered in form or character.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C82392 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25446,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
Flair Changes,absent,Flair_Changes,absent,M_Meningioma_50,M_Meningioma_139,C82392 AND C25446,C48190,"A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest. The act of alteration or modification; changed or altered in form or character.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C82392 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25446,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
sheeting,present,sheeting,present,M_Meningioma_51,M_Meningioma_138,C42587,C25626,Sheet-Like Growth Pattern,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C42587,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
sheeting,absent,sheeting,absent,M_Meningioma_51,M_Meningioma_139,C42587,C48190,Sheet-Like Growth Pattern,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C42587,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
necrosis,present,necrosis,present,M_Meningioma_52,M_Meningioma_138,C16897,C25626,"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16897,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
necrosis,absent,necrosis,absent,M_Meningioma_52,M_Meningioma_139,C16897,C48190,"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16897,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
dural tail,present,dural_tail,present,M_Meningioma_53,M_Meningioma_138,C49332 AND C77663,C25626,"The outermost, toughest, and most fibrous of the membranes (meninges) that surround and protect the brain.A flexible appendage caudal to the sacrum.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49332 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C77663,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
dural tail,absent,dural_tail,absent,M_Meningioma_53,M_Meningioma_139,C49332 AND C77663,C48190,"The outermost, toughest, and most fibrous of the membranes (meninges) that surround and protect the brain.A flexible appendage caudal to the sacrum.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49332 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C77663,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
psammomatous calcification,present,psammomatous_calcification,present,M_Meningioma_54,M_Meningioma_138,,C25626,"Psammomatous calcification refers to the presence of concentrically laminated, round, calcified structures (psammoma bodies) within tissues, usually associated with certain tumors or chronic pathological processes.",Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
psammomatous calcification,absent,psammomatous_calcification,absent,M_Meningioma_54,M_Meningioma_139,,C48190,"Psammomatous calcification refers to the presence of concentrically laminated, round, calcified structures (psammoma bodies) within tissues, usually associated with certain tumors or chronic pathological processes.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
Diffusion Restriction,present,Diffusion_Restriction,present,M_Meningioma_55,M_Meningioma_138,C182357,C25626,A radiologic finding seen as high-signal intensity on diffusion weighted imaging with corresponding reduced apparent diffusion coefficient (ADC) values. ADC is a measurement of the diffusion of water molecules in a given tissue.,Being or existing in a specified place or at the specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182357,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626
Diffusion Restriction,absent,Diffusion_Restriction,absent,M_Meningioma_55,M_Meningioma_139,C182357,C48190,A radiologic finding seen as high-signal intensity on diffusion weighted imaging with corresponding reduced apparent diffusion coefficient (ADC) values. ADC is a measurement of the diffusion of water molecules in a given tissue.,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182357,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
T1,Iso-intense,T1,Iso_intense,M_Meningioma_56,M_Meningioma_143,C180727,C28044,A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the longitudinal relaxation of a tissue's net magnetization vector; it measures the time taken for spinning protons to realign with the external magnetic field. This MRI sequence is produced by using short time to echo (TE) and repetition times (TR).,"Areas that have the same intensity as other objects on imaging scans. 
Having the same intensity as another object. Used to describe the results of imaging tests, such as x-rays, MRIs, or CT scans.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C180727,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28044
T1,Hyper-intensity,T1,Hyper_intensity,M_Meningioma_56,M_Meningioma_144,C180727,C182328,A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the longitudinal relaxation of a tissue's net magnetization vector; it measures the time taken for spinning protons to realign with the external magnetic field. This MRI sequence is produced by using short time to echo (TE) and repetition times (TR).,Areas of high intensity on types of imaging scans; they appear lighter in color and are often seen with various disease processes.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C180727,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182328
T1,Hypo-intensity,T1,Hypo_intensity,M_Meningioma_56,M_Meningioma_145,C180727,C182326,A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the longitudinal relaxation of a tissue's net magnetization vector; it measures the time taken for spinning protons to realign with the external magnetic field. This MRI sequence is produced by using short time to echo (TE) and repetition times (TR).,Areas of low intensity on types of imaging scans; they appear darker in color and are often seen with various disease processes.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C180727,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182326
T2,Iso-intense,T2,Iso_intense,M_Meningioma_57,M_Meningioma_143,C156447,C28044,MRI imaging based on the observed T2 relaxation time of tissues.,"Areas that have the same intensity as other objects on imaging scans. 
Having the same intensity as another object. Used to describe the results of imaging tests, such as x-rays, MRIs, or CT scans.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C156447,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28044
T2,Hyper-intensity,T2,Hyper_intensity,M_Meningioma_57,M_Meningioma_144,C156447,C182328,MRI imaging based on the observed T2 relaxation time of tissues.,Areas of high intensity on types of imaging scans; they appear lighter in color and are often seen with various disease processes.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C156447,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182328
T2,Hypo-intensity,T2,Hypo_intensity,M_Meningioma_57,M_Meningioma_145,C156447,C182326,MRI imaging based on the observed T2 relaxation time of tissues.,Areas of low intensity on types of imaging scans; they appear darker in color and are often seen with various disease processes.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C156447,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182326
adjuvant RT,Radio surgery received,adjuvant_RT,Radio_surgery_received,M_Meningioma_58,M_Meningioma_146,C15675,C160345,Another treatment used together with the primary treatment. Its purpose is to assist the primary treatment.,None,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C15675,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160345
adjuvant RT,Radio surgery not received,adjuvant_RT,Radio_surgery_not_received,M_Meningioma_58,M_Meningioma_147,C15675,C160346,Another treatment used together with the primary treatment. Its purpose is to assist the primary treatment.,Radiation Therapy Not Received,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C15675,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160346
adjuvant RT,time interval,adjuvant_RT,time_interval,M_Meningioma_58,M_Meningioma_148,C15675,C25330,Another treatment used together with the primary treatment. Its purpose is to assist the primary treatment.,The length of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C15675,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25330
Extent of Resection,Unknown,Extent_of_Resection,Unknown,M_Meningioma_59,M_Meningioma_149,C157443,C17998,"A description of the relative amount of tissue, blood vessel, or organ that has been removed. 
The degree to which the lesion has been cut out, or resected.",A proper value is applicable but not known.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157443,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17998
Extent of Resection,GTR,Extent_of_Resection,GTR,M_Meningioma_59,M_Meningioma_150,C157443,C131672,"A description of the relative amount of tissue, blood vessel, or organ that has been removed. 
The degree to which the lesion has been cut out, or resected.","Surgical removal of an entire visible lesion, with no obvious lesion detected on post-operative evaluation; microscopic residual disease may be present.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157443,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C131672
Extent of Resection,STR,Extent_of_Resection,STR,M_Meningioma_59,M_Meningioma_151,C157443,NCIT_C131680,"A description of the relative amount of tissue, blood vessel, or organ that has been removed. 
The degree to which the lesion has been cut out, or resected.",Surgical removal of a part of a lesion; some portion of the lesion is detectable on post-operative evaluation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157443,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C131680
lower limb,grade,lower_limb,grade,M_Meningioma_60,M_Meningioma_152,C12742,C48309,"The limb that is composed of the hip, thigh, leg and foot.",A position on a scale of intensity or amount or quality.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12742,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48309
lower limb,left,lower_limb,left,M_Meningioma_60,M_Meningioma_153,C12742,C25229,"The limb that is composed of the hip, thigh, leg and foot.",Being or located on or directed toward the side of the body to the west when facing north.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12742,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25229
lower limb,right,lower_limb,right,M_Meningioma_60,M_Meningioma_154,C12742,C25228,"The limb that is composed of the hip, thigh, leg and foot.",Being or located on or directed toward the side of the body to the east when facing north.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12742,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25228
upper limb,grade,upper_limb,grade,M_Meningioma_61,M_Meningioma_152,C12671,C48309,The part of the forelimb extending from the shoulder to the autopod.,A position on a scale of intensity or amount or quality.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12671,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48309
upper limb,left,upper_limb,left,M_Meningioma_61,M_Meningioma_153,C12671,C25229,The part of the forelimb extending from the shoulder to the autopod.,Being or located on or directed toward the side of the body to the west when facing north.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12671,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25229
upper limb,right,upper_limb,right,M_Meningioma_61,M_Meningioma_154,C12671,C25228,The part of the forelimb extending from the shoulder to the autopod.,Being or located on or directed toward the side of the body to the east when facing north.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12671,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25228
optic nerve sheath,left optic nerve sheath,optic_nerve_sheath,left_optic_nerve_sheath,M_Meningioma_62,M_Meningioma_155,C4538,C25229 AND C4538,A meningioma that arises from the sheath of the optic nerve.,Being or located on or directed toward the side of the body to the west when facing north. A meningioma that arises from the sheath of the optic nerve.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4538,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25229 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4538
optic nerve sheath,right optic nerve sheath,optic_nerve_sheath,right_optic_nerve_sheath,M_Meningioma_62,M_Meningioma_156,C4538,C25228 AND C4538,A meningioma that arises from the sheath of the optic nerve.,Being or located on or directed toward the side of the body to the east when facing north. A meningioma that arises from the sheath of the optic nerve.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4538,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25228 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4538
involvement of bone,lytic,involvement_of_bone,lytic,M_Meningioma_63,M_Meningioma_157,C25548 AND C12366,C27963,To have a connection by participation or association or use; sharing in an activity or process. Calcified connective tissue that forms the skeletal components of the body.,"Having to do with lysis. In biology, lysis refers to the disintegration of a cell by disruption of its plasma membrane. Lysis can be caused by chemical or physical means (e.g., high-energy sound waves) or by a virus infection.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C27963
involvement of bone,not,involvement_of_bone,not,M_Meningioma_63,M_Meningioma_158,C25548 AND C12366,C110959,To have a connection by participation or association or use; sharing in an activity or process. Calcified connective tissue that forms the skeletal components of the body.,Indicates that no answer was given,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
involvement of bone,sclerotic,involvement_of_bone,sclerotic,M_Meningioma_63,M_Meningioma_159,C25548 AND C12366,C69309,To have a connection by participation or association or use; sharing in an activity or process. Calcified connective tissue that forms the skeletal components of the body.,"A pathological hardening or thickening of tissue, especially that of the interstitial substance.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69309
Tumor size(diameter),> 4cm,Tumor_size_diameter,gt_4cm,M_Meningioma_64,M_Meningioma_160,C120284 AND C25285,C61584 AND C66835 AND C49668,The size of a tumor in its greatest dimension. The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status. A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one. A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C120284 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25285,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61584 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C66835 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49668
Tumor size(diameter),<4cm,Tumor_size_diameter,lt_4cm,M_Meningioma_64,M_Meningioma_161,C120284 AND C25285,C61585 AND C66835 AND C49668,The size of a tumor in its greatest dimension. The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status. A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one. A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C120284 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25285,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61585 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C66835 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49668
Re do surgery,redo surgery not done,Re_do_surgery,redo_surgery_not_done,M_Meningioma_65,M_Meningioma_162,C50830,C50830 AND C216248,Repeat performance of a surgical procedure or intervention.,Repeat performance of a surgical procedure or intervention. A status indicating that the procedure was terminated prior to any activity beyond preparation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C216248
Re do surgery,redo surgery done,Re_do_surgery,redo_surgery_done,M_Meningioma_65,M_Meningioma_163,C50830,C50830 AND C216248,Repeat performance of a surgical procedure or intervention.,Repeat performance of a surgical procedure or intervention. A status indicating that the procedure was terminated prior to any activity beyond preparation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C216248
Re do surgery,time interval,Re_do_surgery,time_interval,M_Meningioma_65,M_Meningioma_148,C50830,C50830 AND C216248,Repeat performance of a surgical procedure or intervention.,Repeat performance of a surgical procedure or intervention. A status indicating that the procedure was terminated prior to any activity beyond preparation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50830 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C216248
MRI,yes,MRI,yes,M_Meningioma_66,M_Meningioma_73,C16809,C49488,"A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones.",The affirmative response to a question,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
MRI,no,MRI,no,M_Meningioma_66,M_Meningioma_114,C16809,C110959,"A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones.",Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
MRI,preoperative,MRI,preoperative,M_Meningioma_66,M_Meningioma_164,C16809,C54732,"A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones.",Relating to or occurring during the period immediately before a surgical operation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54732
MRI,post operative,MRI,post_operative,M_Meningioma_66,M_Meningioma_165,C16809,C28006,"A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones.","After surgery. 
Relating to or occurring during the period immediately following a surgical operation.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28006
follow up mri,yes,follow_up_mri,yes,M_Meningioma_67,M_Meningioma_73,C16033 AND C16809,C49488,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends. A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bone",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
follow up mri,no,follow_up_mri,no,M_Meningioma_67,M_Meningioma_114,C16033 AND C16809,C110959,"Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends. A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bone",Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16033 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
smoking,yes,smoking,yes,M_Meningioma_68,M_Meningioma_73,C154329,C49488,The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C154329,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
smoking,former,smoking,former,M_Meningioma_68,M_Meningioma_166,C154329,C67148,The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.,A person who has quit smoking at the time of the interview but has smoked at least 100 cigarettes in their life.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C154329,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C67148
smoking,current,smoking,current,M_Meningioma_68,M_Meningioma_167,C154329,C67147,The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.,An adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes. Includes daily smokers and non-daily smokers (also known as occasional smokers).,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C154329,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C67147
drugs intake,yes,drugs_intake,yes,M_Meningioma_69,M_Meningioma_73,C459 AND C25538,C49488,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product. The process of taking in a substance, especially by eating or drinking, or the quantities thereof; admittance of people to a place or organization at a particular time.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25538,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
drugs intake,no,drugs_intake,no,M_Meningioma_69,M_Meningioma_114,C459 AND C25538,C110959,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product. The process of taking in a substance, especially by eating or drinking, or the quantities thereof; admittance of people to a place or organization at a particular time.",Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25538,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
drugs intake,specify drugs,drugs_intake,specify_drugs,M_Meningioma_69,M_Meningioma_168,C459 AND C25538,C459,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product. The process of taking in a substance, especially by eating or drinking, or the quantities thereof; admittance of people to a place or organization at a particular time.","A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25538,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
brain tumor,yes,brain_tumor,yes,M_Meningioma_70,M_Meningioma_73,C2907,C49488,A benign or malignant neoplasm that arises from or metastasizes to the brain.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2907,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
brain tumor,duration,brain_tumor,duration,M_Meningioma_70,M_Meningioma_169,C2907,NCIT_C25330,A benign or malignant neoplasm that arises from or metastasizes to the brain.,The period of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2907,http://purl.obolibrary.org/obo/NCIT_C25330
brain tumor,no,brain_tumor,no,M_Meningioma_70,M_Meningioma_114,C2907,C110959,A benign or malignant neoplasm that arises from or metastasizes to the brain.,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2907,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
brain tumor,specify drugs,brain_tumor,specify_drugs,M_Meningioma_70,M_Meningioma_168,C2907,C459,A benign or malignant neoplasm that arises from or metastasizes to the brain.,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2907,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
CT scan,yes,CT_scan,yes,M_Meningioma_71,M_Meningioma_73,C45844,C49488,"CT (Computerized (Axial) Tomography) scanner is a special kind of machine which directs a series of X-ray pulses through the body, to produce detailed pictures of internal body structures.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C45844,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
CT scan,no,CT_scan,no,M_Meningioma_71,M_Meningioma_114,C45844,C110959,"CT (Computerized (Axial) Tomography) scanner is a special kind of machine which directs a series of X-ray pulses through the body, to produce detailed pictures of internal body structures.",Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C45844,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
CT scan,preoperative,CT_scan,preoperative,M_Meningioma_71,M_Meningioma_164,C45844,C54732,"CT (Computerized (Axial) Tomography) scanner is a special kind of machine which directs a series of X-ray pulses through the body, to produce detailed pictures of internal body structures.",Relating to or occurring during the period immediately before a surgical operation.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C45844,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54732
CT scan,post operative,CT_scan,post_operative,M_Meningioma_71,M_Meningioma_165,C45844,C28006,"CT (Computerized (Axial) Tomography) scanner is a special kind of machine which directs a series of X-ray pulses through the body, to produce detailed pictures of internal body structures.","After surgery. NCI-GLOSS 
Relating to or occurring during the period immediately following a surgical operation.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C45844,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28006
other malignancies,yes,other_malignancies,yes,M_Meningioma_72,M_Meningioma_73,C194802,C49488,Evidence of other malignant immunoproliferative diseases not specified elsewhere.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C194802,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
other malignancies,duration,other_malignancies,duration,M_Meningioma_72,M_Meningioma_169,C194802,NCIT_C25330,Evidence of other malignant immunoproliferative diseases not specified elsewhere.,The period of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C194802,http://purl.obolibrary.org/obo/NCIT_C25330
other malignancies,no,other_malignancies,no,M_Meningioma_72,M_Meningioma_114,C194802,C110959,Evidence of other malignant immunoproliferative diseases not specified elsewhere.,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C194802,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
other malignancies,specify drugs,other_malignancies,specify_drugs,M_Meningioma_72,M_Meningioma_168,C194802,C459,Evidence of other malignant immunoproliferative diseases not specified elsewhere.,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C194802,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
others,yes,others,yes,M_Meningioma_73,M_Meningioma_73,C168369,C49488,An indication that the primary reason for a patient visit to a healthcare provider is other than those listed.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168369,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
others,duration,others,duration,M_Meningioma_73,M_Meningioma_169,C168369,NCIT_C25330,An indication that the primary reason for a patient visit to a healthcare provider is other than those listed.,The period of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168369,http://purl.obolibrary.org/obo/NCIT_C25330
others,no,others,no,M_Meningioma_73,M_Meningioma_114,C168369,C110959,An indication that the primary reason for a patient visit to a healthcare provider is other than those listed.,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168369,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
others,specify drugs,others,specify_drugs,M_Meningioma_73,M_Meningioma_168,C168369,C459,An indication that the primary reason for a patient visit to a healthcare provider is other than those listed.,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168369,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
involvement of surrounding tissue,yes,involvement_of_surrounding_tissue,yes,M_Meningioma_74,M_Meningioma_73,C52247 AND C12801 AND C25548,C49488,Extending on all sides of simultaneously; A group or layer of cells that work together to perform a specific function; To have a connection by participation or association or use; sharing in an activity or process.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C52247 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12801 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
involvement of surrounding tissue,Not,involvement_of_surrounding_tissue,Not,M_Meningioma_74,M_Meningioma_170,C52247 AND C12801 AND C25548,C110959,Extending on all sides of simultaneously; A group or layer of cells that work together to perform a specific function; To have a connection by participation or association or use; sharing in an activity or process.,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C52247 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12801 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
Pial invasion,yes,Pial_invasion,yes,M_Meningioma_75,M_Meningioma_73,RID7101 AND RID39257,C49488,Tumor invasion of the pia mater of neuraxis,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/radlex/RID7101 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/radlex/RID39257,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
Pial invasion,Not,Pial_invasion,Not,M_Meningioma_75,M_Meningioma_170,RID7101 AND RID39257,C110959,Tumor invasion of the pia mater of neuraxis,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/radlex/RID7101 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/radlex/RID39257,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
throid disorder,yes,throid_disorder,yes,M_Meningioma_76,M_Meningioma_73,C26893,C49488,"A non-neoplastic or neoplastic disorder that affects the thyroid gland. Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.",The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26893,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
throid disorder,duration,throid_disorder,duration,M_Meningioma_76,M_Meningioma_169,C26893,NCIT_C25330,"A non-neoplastic or neoplastic disorder that affects the thyroid gland. Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.",The period of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26893,http://purl.obolibrary.org/obo/NCIT_C25330
throid disorder,no,throid_disorder,no,M_Meningioma_76,M_Meningioma_114,C26893,C110959,"A non-neoplastic or neoplastic disorder that affects the thyroid gland. Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.",Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26893,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
throid disorder,specify drugs,throid_disorder,specify_drugs,M_Meningioma_76,M_Meningioma_168,C26893,C459,"A non-neoplastic or neoplastic disorder that affects the thyroid gland. Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.","A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26893,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
surgery,yes,surgery,yes,M_Meningioma_77,M_Meningioma_73,C17173,C49488,The branch of medical science that treats disease or injury by operative procedures.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17173,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
surgery,no,surgery,no,M_Meningioma_77,M_Meningioma_114,C17173,C110959,The branch of medical science that treats disease or injury by operative procedures.,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17173,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
diabetes,yes,diabetes,yes,M_Meningioma_78,M_Meningioma_73,C2985,C49488,A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.,The affirmative response to a question.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49488
diabetes,duration,diabetes,duration,M_Meningioma_78,M_Meningioma_169,C2985,NCIT_C25330,A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.,The period of time during which something continues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,http://purl.obolibrary.org/obo/NCIT_C25330
diabetes,no,diabetes,no,M_Meningioma_78,M_Meningioma_114,C2985,C110959,A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.,Indicates that no answer was given.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C110959
diabetes,specify drugs,diabetes,specify_drugs,M_Meningioma_78,M_Meningioma_168,C2985,C459,A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.,"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C459
right convexity,frontal,right_convexity,frontal,M_Meningioma_79,M_Meningioma_171,C4959,C5292,A meningioma that affects the cerebral sulcus.,A meningioma that affects the frontal sulcus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5292
right convexity,occipital,right_convexity,occipital,M_Meningioma_79,M_Meningioma_172,C4959,C177767,A meningioma that affects the cerebral sulcus.,"The grey matter, or outermost layer of the occipital lobe. 
The outermost layer of the occipital lobe of the brain, made up of gray matter.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C177767
right convexity,cerebellar,right_convexity,cerebellar,M_Meningioma_79,M_Meningioma_173,C4959,C12445,A meningioma that affects the cerebral sulcus.,"Brain structure derived from the anterior hindbrain, and perhaps including posterior midbrain. The cerebellum plays a role in somatic motor function, the control of muscle tone, and balance.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12445
right convexity,temporal,right_convexity,temporal,M_Meningioma_79,M_Meningioma_174,C4959,C117754,A meningioma that affects the cerebral sulcus.,"Of, or related to, anatomic sites that are located in the cranium, brain, and eye. 
Of, or related to, or in the direction of the anatomic sites that are located in the temple.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C117754
right convexity,parietal,right_convexity,parietal,M_Meningioma_79,M_Meningioma_175,C4959,C177764,A meningioma that affects the cerebral sulcus.,"The outermost layer of the parietal lobe of the brain, made up primarily of gray matter. 
The outermost layer of the parietal lobe, made up primarily of gray matter.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C177764
left convexity,frontal,left_convexity,frontal,M_Meningioma_80,M_Meningioma_171,C4959,C5292,A meningioma that affects the cerebral sulcus.,A meningioma that affects the frontal sulcus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5292
left convexity,occipital,left_convexity,occipital,M_Meningioma_80,M_Meningioma_172,C4959,C177767,A meningioma that affects the cerebral sulcus.,"The grey matter, or outermost layer of the occipital lobe. 
The outermost layer of the occipital lobe of the brain, made up of gray matter.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C177767
left convexity,cerebellar,left_convexity,cerebellar,M_Meningioma_80,M_Meningioma_173,C4959,C12445,A meningioma that affects the cerebral sulcus.,"Brain structure derived from the anterior hindbrain, and perhaps including posterior midbrain. The cerebellum plays a role in somatic motor function, the control of muscle tone, and balance.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12445
left convexity,temporal,left_convexity,temporal,M_Meningioma_80,M_Meningioma_174,C4959,C117754,A meningioma that affects the cerebral sulcus.,"Of, or related to, anatomic sites that are located in the cranium, brain, and eye. 
Of, or related to, or in the direction of the anatomic sites that are located in the temple.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C117754
left convexity,parietal,left_convexity,parietal,M_Meningioma_80,M_Meningioma_175,C4959,C177764,A meningioma that affects the cerebral sulcus.,"The outermost layer of the parietal lobe of the brain, made up primarily of gray matter. 
The outermost layer of the parietal lobe, made up primarily of gray matter.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4959,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C177764
disease,hypertension,disease,hypertension,M_Meningioma_81,M_Meningioma_19,C2991,C3117,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.","A blood pressure of 140/90 or higher. High blood pressure usually has no symptoms. It can harm the arteries and cause an increase in the risk of stroke, heart attack, kidney failure, and blindness.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3117
disease,brain tumor,disease,brain_tumor,M_Meningioma_81,M_Meningioma_176,C2991,C2907,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.",A benign or malignant neoplasm that arises from or metastasizes to the brain.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2907
disease,other malignancies,disease,other_malignancies,M_Meningioma_81,M_Meningioma_177,C2991,C50477,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.",A finding indicating the presence of a malignancy that is not further specified or defined.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C50477
disease,others,disease,others,M_Meningioma_81,M_Meningioma_116,C2991,C168369,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.",An indication that the primary reason for a patient visit to a healthcare provider is other than those listed.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C168369
disease,throid disorder,disease,throid_disorder,M_Meningioma_81,M_Meningioma_178,C2991,C26893,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.","non-neoplastic or neoplastic disorder that affects the thyroid gland. Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C26893
disease,diabetes,disease,diabetes,M_Meningioma_81,M_Meningioma_179,C2991,C2985,"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the affected person. NOTE: The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. [After NCI Thesaurus] See also diagnosis.",A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2991,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2985
imaging assessment factors,brightness,imaging_assessment_factors,brightness,M_Meningioma_82,M_Meningioma_180,,C70753,"Imaging assessment factors are the set of technical, visual, and diagnostic parameters used to evaluate the quality, reliability, and adequacy of an image (microscopic, radiologic, or digital) for clinical interpretation, research, or computational analysis.",An indication of the relative light intensity of a source or object.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70753
imaging assessment factors,uniform illumination,imaging_assessment_factors,uniform_illumination,M_Meningioma_82,M_Meningioma_181,,,"Imaging assessment factors are the set of technical, visual, and diagnostic parameters used to evaluate the quality, reliability, and adequacy of an image (microscopic, radiologic, or digital) for clinical interpretation, research, or computational analysis.","Illumination in MRI can be defined as the strength of the spin transition from the lower to the upper energy state, which is attributed to the effect of the B1+-field in the excitation phase, where the RF coil acts as a transmitter.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,"https://www.cei.se/fundamentals-of-magnetic-resonance-imaging-mri#:~:text=Homogeneity%20of%20the%20B1%2B%2D,coil%20acts%20as%20a%20transmitter."
imaging assessment factors,sharpness,imaging_assessment_factors,sharpness,M_Meningioma_82,M_Meningioma_182,,,"Imaging assessment factors are the set of technical, visual, and diagnostic parameters used to evaluate the quality, reliability, and adequacy of an image (microscopic, radiologic, or digital) for clinical interpretation, research, or computational analysis.",Sharpness is arguably the most important single image quality factor: it determines the amount of detail an image can convey.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://www.imatest.com/imaging/sharpness/
imaging assessment factors,contrast,imaging_assessment_factors,contrast,M_Meningioma_82,M_Meningioma_183,,C70754,"Imaging assessment factors are the set of technical, visual, and diagnostic parameters used to evaluate the quality, reliability, and adequacy of an image (microscopic, radiologic, or digital) for clinical interpretation, research, or computational analysis.",The degree of difference between the lightest and darkest areas of an image or object.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70754
Quality assessment of Slide assessment,brightness,Quality_assessment_of_Slide_assessment,brightness,M_Meningioma_83,M_Meningioma_180,,C70753,Quality assessment of a histopathology slide is the systematic evaluation of technical and visual parameters of a prepared glass or digital slide to determine its adequacy for diagnostic interpretation or research use.,An indication of the relative light intensity of a source or object.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70753
Quality assessment of Slide assessment,uniform illumination,Quality_assessment_of_Slide_assessment,uniform_illumination,M_Meningioma_83,M_Meningioma_181,,,Quality assessment of a histopathology slide is the systematic evaluation of technical and visual parameters of a prepared glass or digital slide to determine its adequacy for diagnostic interpretation or research use.,"Histopathology image illumination refers to the quality, uniformity, and stability of light distributed across a stained tissue section during microscopic visualization or whole-slide digital imaging. Proper illumination ensures accurate representation of tissue morphology, color balance of stains, and reproducibility of diagnostic features.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
Quality assessment of Slide assessment,sharpness,Quality_assessment_of_Slide_assessment,sharpness,M_Meningioma_83,M_Meningioma_182,,,Quality assessment of a histopathology slide is the systematic evaluation of technical and visual parameters of a prepared glass or digital slide to determine its adequacy for diagnostic interpretation or research use.,"Image sharpness refers to the degree to which fine structural details and boundaries within an image are well-defined and distinguishable. In medical and histopathology imaging, sharpness reflects the systemâ€™s ability to reproduce edges and textures without blurring, directly influencing diagnostic accuracy.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
Quality assessment of Slide assessment,H & E staining,Quality_assessment_of_Slide_assessment,H_E_staining,M_Meningioma_83,M_Meningioma_184,,C23011,Quality assessment of a histopathology slide is the systematic evaluation of technical and visual parameters of a prepared glass or digital slide to determine its adequacy for diagnostic interpretation or research use.,"Hematoxylin-and-eosin, or H&E, is a routine staining procedure of tissue sections. This staining method uses two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C23011
Quality assessment of Slide assessment,contrast,Quality_assessment_of_Slide_assessment,contrast,M_Meningioma_83,M_Meningioma_183,,C70754,Quality assessment of a histopathology slide is the systematic evaluation of technical and visual parameters of a prepared glass or digital slide to determine its adequacy for diagnostic interpretation or research use.,The degree of difference between the lightest and darkest areas of an image or object.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70754
Quality assessment of Slide assessment,presence of artifacts,Quality_assessment_of_Slide_assessment,presence_of_artifacts,M_Meningioma_83,M_Meningioma_185,,C87020,Quality assessment of a histopathology slide is the systematic evaluation of technical and visual parameters of a prepared glass or digital slide to determine its adequacy for diagnostic interpretation or research use.,An artifact resulting from data processing steps after capture of an image.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C87020
neurofibromatosis,NF1,neurofibromatosis,NF1,M_Meningioma_84,M_Meningioma_186,C6727,C3273,"An autosomal dominant hereditary neoplastic syndrome. Two distinct clinicopathological entities are recognized: neurofibromatosis type 1 and neurofibromatosis type 2. Neurofibromatosis type 1 is associated with the presence of cafe-au-lait cutaneous lesions, multiple neurofibromas, malignant peripheral nerve sheath tumors, optic nerve gliomas, and bone lesions. Neurofibromatosis type 2 is associated with the presence of schwannomas, meningiomas, and gliomas.","The most common type of neurofibromatosis. It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface. They can vary markedly in size and color. The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas. They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures. Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6727,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3273
neurofibromatosis,absent,neurofibromatosis,absent,M_Meningioma_84,M_Meningioma_139,C6727,C48190,"An autosomal dominant hereditary neoplastic syndrome. Two distinct clinicopathological entities are recognized: neurofibromatosis type 1 and neurofibromatosis type 2. Neurofibromatosis type 1 is associated with the presence of cafe-au-lait cutaneous lesions, multiple neurofibromas, malignant peripheral nerve sheath tumors, optic nerve gliomas, and bone lesions. Neurofibromatosis type 2 is associated with the presence of schwannomas, meningiomas, and gliomas.",Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6727,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190
neurofibromatosis,NF2,neurofibromatosis,NF2,M_Meningioma_84,M_Meningioma_187,C6727,C3274,"An autosomal dominant hereditary neoplastic syndrome. Two distinct clinicopathological entities are recognized: neurofibromatosis type 1 and neurofibromatosis type 2. Neurofibromatosis type 1 is associated with the presence of cafe-au-lait cutaneous lesions, multiple neurofibromas, malignant peripheral nerve sheath tumors, optic nerve gliomas, and bone lesions. Neurofibromatosis type 2 is associated with the presence of schwannomas, meningiomas, and gliomas.","An autosomal dominant disorder caused by mutations in the NF2 tumor suppressor gene. It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6727,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3274
CT finding,involvement of bone,CT_finding,involvement_of_bone,M_Meningioma_85,M_Meningioma_188,C35869,C25548 AND C12366,"Imaging results obtained through a radiology procedure. NCI 
Objective evidence of disease perceptible to the examiner by radiological procedure.",To have a connection by participation or association or use; Calcified connective tissue that forms the skeletal components of the body.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C35869,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25548 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366
Evaluation of tumor tissue,Volume of tissue,Evaluation_of_tumor_tissue,Volume_of_tissue,M_Meningioma_86,M_Meningioma_189,C93427,C25335 AND C12801,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,The amount of three dimensional space occupied by an object or the capacity of a space or container; A group or layer of cells that work together to perform a specific function.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25335 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12801
Evaluation of tumor tissue,identification of invasive tumor front,Evaluation_of_tumor_tissue,identification_of_invasive_tumor_front,M_Meningioma_86,M_Meningioma_190,C93427,C137710,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,Describes a tumor border that is invading the adjacent tissue.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137710
Evaluation of tumor tissue,Evaluation of dura,Evaluation_of_tumor_tissue,Evaluation_of_dura,M_Meningioma_86,M_Meningioma_191,C93427,C25214 AND C32488,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria of the outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C32488
Evaluation of tumor tissue,identification of lesional area,Evaluation_of_tumor_tissue,identification_of_lesional_area,M_Meningioma_86,M_Meningioma_192,C93427,C94189,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,An indication that a lesion has been located and characterized.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C94189
Evaluation of tumor tissue,Evaluation of bone,Evaluation_of_tumor_tissue,Evaluation_of_bone,M_Meningioma_86,M_Meningioma_193,C93427,C25214 AND C12366,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria. Calcified connective tissue that forms the skeletal components of the body.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25214 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12366
Evaluation of tumor tissue,morphology,Evaluation_of_tumor_tissue,morphology,M_Meningioma_86,M_Meningioma_194,C93427,C17943,The completed assessment for findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.,A statement about the form and/or structure of a target entity.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C93427,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C17943
simpson grade,grade 0,simpson_grade,grade_0,M_Meningioma_87,M_Meningioma_195,C128616,C175027,A scale that defines the extent of resection involved in the removal of intracranial meningiomas.,"Resection of a tissue structure, most often a lesion, with histologically proven negative surgical margins, or an organ that contains a lesion.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128616,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C175027
simpson grade,grade IV,simpson_grade,grade_IV,M_Meningioma_87,M_Meningioma_196,C128616,C128620,A scale that defines the extent of resection involved in the removal of intracranial meningiomas.,"Partial removal, leaving the intradural tumor in situ.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128616,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128620
simpson grade,grade II,simpson_grade,grade_II,M_Meningioma_87,M_Meningioma_197,C128616,C128618,A scale that defines the extent of resection involved in the removal of intracranial meningiomas.,Macroscopically complete removal of the tumor and its visible extensions with coagulation of its dural attachment.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128616,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128618
simpson grade,grade I,simpson_grade,grade_I,M_Meningioma_87,M_Meningioma_198,C128616,C128617,A scale that defines the extent of resection involved in the removal of intracranial meningiomas.,"Macroscopically complete removal of the tumor, with excision of its dural attachment, and of any abnormal bone. Includes resection of venous sinus if involved.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128616,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128617
simpson grade,grade III,simpson_grade,grade_III,M_Meningioma_87,M_Meningioma_199,C128616,C128619,A scale that defines the extent of resection involved in the removal of intracranial meningiomas.,"Macroscopically complete removal of the intradural tumor, without resection or coagulation of its dural attachment or its extradural extensions.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128616,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128619
Assessing MRI Sequences,Flair Changes,Assessing_MRI_Sequences,Flair_Changes,M_Meningioma_88,M_Meningioma_200,NCIT_C115501,C82392 AND C25446,A collection of magnetic resonance image files pertaining to a clinical study.,"A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest. The act of alteration or modification; changed or altered in form or character.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C115501,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C82392 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25446
Assessing MRI Sequences,T1,Assessing_MRI_Sequences,T1,M_Meningioma_88,M_Meningioma_201,NCIT_C115501,C180727,A collection of magnetic resonance image files pertaining to a clinical study.,A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the longitudinal relaxation of a tissue's net magnetization vector; it measures the time taken for spinning protons to realign with the external magnetic field. This MRI sequence is produced by using short time to echo (TE) and repetition times (TR).,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C115501,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C180727
Assessing MRI Sequences,Diffusion Restriction,Assessing_MRI_Sequences,Diffusion_Restriction,M_Meningioma_88,M_Meningioma_202,NCIT_C115501,C182357,A collection of magnetic resonance image files pertaining to a clinical study.,A radiologic finding seen as high-signal intensity on diffusion weighted imaging with corresponding reduced apparent diffusion coefficient (ADC) values. ADC is a measurement of the diffusion of water molecules in a given tissue. NCI,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C115501,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182357
Assessing MRI Sequences,T2,Assessing_MRI_Sequences,T2,M_Meningioma_88,M_Meningioma_203,NCIT_C115501,C156447,A collection of magnetic resonance image files pertaining to a clinical study.,MRI imaging based on the observed T2 relaxation time of tissues.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C115501,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C156447
Assessing MRI Sequences,Contrast Enhancement,Assessing_MRI_Sequences,Contrast_Enhancement,M_Meningioma_88,M_Meningioma_204,NCIT_C115501,C199692,A collection of magnetic resonance image files pertaining to a clinical study.,The phase of the contrast agent distribution within the body after its administration.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://purl.obolibrary.org/obo/NCIT_C115501,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C199692
Skull base,midline,Skull_base,midline,M_Meningioma_89,M_Meningioma_205,C5272,C162614,"Attribution
A meningioma that arises from the skull base.",A finding indicating the tumor location is on the midline of the specimen.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5272,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614
Skull base,Lateral,Skull_base,Lateral,M_Meningioma_89,M_Meningioma_206,C5272,C25230,"Attribution
A meningioma that arises from the skull base.",Situated at or extending to the side.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5272,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25230
Skull base,Tentorial,Skull_base,Tentorial,M_Meningioma_89,M_Meningioma_207,C5272,C33749,"Attribution
A meningioma that arises from the skull base.",A dural partition that separates the occipital lobes of the cerebrum from the cerebellum and divides the cranial cavity into supratentorial and infratentorial compartments; it helps to stabilize the brain within the cranial cavity.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5272,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C33749
Who Grade III,Papillary,Who_Grade_III,Papillary,M_Meningioma_90,M_Meningioma_208,C62396,C3904,Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.,A WHO grade 3 meningioma characterized by the predominance of a perivascular pseudopapillary pattern.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62396,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3904
Who Grade III,Anaplastic,Who_Grade_III,Anaplastic,M_Meningioma_90,M_Meningioma_209,C62396,C4051,Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.,"A WHO grade 3 meningioma characterized by the presence of malignant morphologic features, including malignant cytology and a very high mitotic index (20 or more mitoses per ten high power fields).",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62396,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4051
Who Grade III,Rhabdoid,Who_Grade_III,Rhabdoid,M_Meningioma_90,M_Meningioma_210,C62396,C6909,Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.,A WHO grade 3 meningioma characterized by the predominant presence of rhabdoid cells forming sheets.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62396,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6909
WHO Grade II,Papillary,WHO_Grade_II,Papillary,M_Meningioma_91,M_Meningioma_208,C62396,C3904,Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.,A WHO grade 3 meningioma characterized by the predominance of a perivascular pseudopapillary pattern.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62396,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3904
WHO Grade II,Atypical,WHO_Grade_II,Atypical,M_Meningioma_91,M_Meningioma_211,C62395,C4723,Describes central nervous system tumors that are generally relatively slow growing and somewhat infiltrative. They may recur after treatment.,"A WHO grade II meningioma characterized by the presence of brain invasion and an increased mitotic activity, or at least three of the following morphologic features: small cells, high cellularity, prominent nucleoli, lack of architectural pattern, and necrosis.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62395,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4723
WHO Grade II,Chordoid,WHO_Grade_II,Chordoid,M_Meningioma_91,M_Meningioma_212,C62395,C6908,Describes central nervous system tumors that are generally relatively slow growing and somewhat infiltrative. They may recur after treatment.,"A WHO grade II, usually recurring meningioma characterized by the predominance of tissues that are histologically similar to chordoma.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62395,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6908
WHO Grade II,Clear cell,WHO_Grade_II,Clear_cell,M_Meningioma_91,M_Meningioma_213,C62395,C4722,Describes central nervous system tumors that are generally relatively slow growing and somewhat infiltrative. They may recur after treatment.,A WHO grade II morphologic variant of meningioma characterized by the presence of clear glycogen-rich polygonal cells.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62395,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4722
WHO Grade II,Rhabdoid,WHO_Grade_II,Rhabdoid,M_Meningioma_91,M_Meningioma_210,C62396,C6909,Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.,A WHO grade 3 meningioma characterized by the predominant presence of rhabdoid cells forming sheets.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C62396,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6909
Description of lesion,Tumor Location,Description_of_lesion,Tumor_Location,M_Meningioma_92,M_Meningioma_214,C166231,NCIt - C25376,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",Anatomical site where the tumor is located.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231
Description of lesion,Number of lesion,Description_of_lesion,Number_of_lesion,M_Meningioma_92,M_Meningioma_215,C166231,C174277,"Specifies the description of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",The number of lesions observed.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C166231,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C174277
imaging equipment utilized,3D HISTECH slide scanner,imaging_equipment_utilized,3D_HISTECH_slide_scanner,M_Meningioma_93,M_Meningioma_216,C69194,C69194,"Imaging equipment utilized refers to the medical devices and technologies employed to generate visual representations of internal body structures and functions for the purpose of diagnosis, treatment planning, monitoring, and research.","Equipment used to analyze, enhance, interpret or display digital images.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69194,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69194
imaging equipment utilized,Binocular light microscope with attached camera,imaging_equipment_utilized,Binocular_light_microscope_with_attached_camera,M_Meningioma_93,M_Meningioma_217,C69194,C28265 AND C49858,"Imaging equipment utilized refers to the medical devices and technologies employed to generate visual representations of internal body structures and functions for the purpose of diagnosis, treatment planning, monitoring, and research.","A microscope (device to magnify small objects) in which objects are lit directly by white light; An apparatus for taking photographs, generally consisting of a lightproof enclosure having an aperture with a shuttered lens through which the image of an object is focused and recorded on a photosensitive film or plate.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69194,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28265 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49858
Borders,Regular,Borders,Regular,M_Meningioma_94,M_Meningioma_218,C80507,C25647,A boundary line or the area immediately inside the boundary.,"Customary, usual, or at fixed intervals; conforming to a standard or pattern.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C80507,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25647
Borders,Irregular,Borders,Irregular,M_Meningioma_94,M_Meningioma_219,C80507,C63815,A boundary line or the area immediately inside the boundary.,Lacking perfect symmetry or evenness.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C80507,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C63815
preoperative,no of pre-op scans,preoperative,no_of_pre_op_scans,M_Meningioma_95,M_Meningioma_220,C54732,,Relating to or occurring during the period immediately before a surgical operation.,"An imaging metadata attribute that represents the count of diagnostic imaging examinations performed prior to a surgical or interventional procedure. It specifies how many distinct imaging studies (e.g., MRI, CT, PET, X-ray) were conducted for pre-operative assessment of a patient.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54732,
MR imaging equipment utilized,CT Scan Machine,MR_imaging_equipment_utilized,CT_Scan_Machine,M_Meningioma_96,M_Meningioma_221,,C45844,"An imaging metadata attribute that specifies the particular magnetic resonance (MR) scanner or hardware system employed in the acquisition of MR images, including details such as manufacturer, model, field strength, and coil configuration, which may influence image quality and diagnostic characteristics.","CT (Computerized (Axial) Tomography) scanner is a special kind of machine which directs a series of X-ray pulses through the body, to produce detailed pictures of internal body structures.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C45844
MR imaging equipment utilized,MRI machine,MR_imaging_equipment_utilized,MRI_machine,M_Meningioma_96,M_Meningioma_222,,C16809 AND C69194,"An imaging metadata attribute that specifies the particular magnetic resonance (MR) scanner or hardware system employed in the acquisition of MR images, including details such as manufacturer, model, field strength, and coil configuration, which may influence image quality and diagnostic characteristics.","A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones. Equipment that has processed composite instances to create new composite instances. For example, a 3D Workstation.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C16809 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C69194
Quality assessment of MRI scanners,imaging assessment factors,Quality_assessment_of_MRI_scanners,imaging_assessment_factors,M_Meningioma_97,M_Meningioma_223,,,"Quality assessment of MRI scanners is the systematic evaluation of an MRI systemâ€™s performance using standardized tests, phantoms, and metrics to ensure that image quality, safety, and technical parameters meet clinical, regulatory, and diagnostic standards. It forms a critical component of MRI quality control (QC) and quality assurance (QA) programs.","Radiology imaging assessment factors are the standardized technical and perceptual parameters used to evaluate the adequacy, diagnostic quality, and reliability of radiologic images (CT, MRI, X-ray, Ultrasound, PET) for accurate clinical interpretation and reporting.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
midline,olfactory groove,midline,olfactory_groove,M_Meningioma_98,M_Meningioma_224,C162614,C6771,A finding indicating the tumor location is on the midline of the specimen.,A meningioma that affects the olfactory sulcus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C6771
midline,planum sphenoidale,midline,planum_sphenoidale,M_Meningioma_98,M_Meningioma_225,C162614,C180372,A finding indicating the tumor location is on the midline of the specimen.,"The portion of the skull that is formed laterally by the orbital plates of the frontal bone, medially by the cribriform palate and crista galli of the ethmoid bone, and posteriorly by the planum sphenoidale and lesser wings of the sphenoid bone.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C180372
midline,tuberculum sella,midline,tuberculum_sella,M_Meningioma_98,M_Meningioma_226,C162614,C5284,A finding indicating the tumor location is on the midline of the specimen.,A meningioma that arises from the tuberculum sellae.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5284
midline,petroclivus,midline,petroclivus,M_Meningioma_98,M_Meningioma_227,C162614,C95442 AND C12494,A finding indicating the tumor location is on the midline of the specimen.,"Pertaining to the petrous or hard, stony portion of the temporal bone; A sloped depression between the dorsum sellae and foramen magnum at the base of the skull.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C95442 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12494
midline,diaphragm sella,midline,diaphragm_sella,M_Meningioma_98,M_Meningioma_228,C162614,C5283,A finding indicating the tumor location is on the midline of the specimen.,A meningioma that arises from the diaphragma sellae.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5283
midline,clivus,midline,clivus,M_Meningioma_98,M_Meningioma_229,C162614,C5289,A finding indicating the tumor location is on the midline of the specimen.,A meningioma that affects the clivus.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C162614,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5289
Operative Details,Extent of Resection,Operative_Details,Extent_of_Resection,M_Meningioma_99,M_Meningioma_230,NCIT_C15329,C157443,"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","A description of the relative amount of tissue, blood vessel, or organ that has been removed. CDISC 
The degree to which the lesion has been cut out, or resected.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C15329,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157443
Operative Details,simpson grade,Operative_Details,simpson_grade,M_Meningioma_99,M_Meningioma_231,NCIT_C15329,C128616,"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.",A scale that defines the extent of resection involved in the removal of intracranial meningiomas.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C15329,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C128616
Histopathological diagnosis,other,Histopathological_diagnosis,other,M_Meningioma_100,M_Meningioma_232,C164406,C159613,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",A selected option that indicated an other histologic type.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C159613
Histopathological diagnosis,Inflammatory granulomatous lesions,Histopathological_diagnosis,Inflammatory_granulomatous_lesions,M_Meningioma_100,M_Meningioma_233,C164406,C25302,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",Relating to or characterized by granulomas.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25302
Histopathological diagnosis,Solitary fibrous tumor ICD-O-3-2 8815/1,Histopathological_diagnosis,Solitary_fibrous_tumor_ICD_O_3_2_8815_1,M_Meningioma_100,M_Meningioma_234,C164406,C7634,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):","A localized neoplasm of probable fibroblastic derivation. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C7634
Histopathological diagnosis,meningioma ICD-O-3-2 9530/0,Histopathological_diagnosis,meningioma_ICD_O_3_2_9530_0,M_Meningioma_100,M_Meningioma_235,C164406,C3230,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",A type of slow-growing tumor that forms in the meninges (thin layers of tissue that cover and protect the brain and spinal cord). Meningiomas usually occur in adults.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3230
Histopathological diagnosis,Lymphoma ICD-O-3-2 9680/3,Histopathological_diagnosis,Lymphoma_ICD_O_3_2_9680_3,M_Meningioma_100,M_Meningioma_236,C164406,C3208,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):","A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3208
Histopathological diagnosis,Hemagiopericytoma ICD-O-3-2-9161/1,Histopathological_diagnosis,Hemagiopericytoma_ICD_O_3_2_9161_1,M_Meningioma_100,M_Meningioma_237,C164406,C3087,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",An antiquated term that refers to benign or malignant mesenchymal neoplasms characterized by the presence of neoplastic spindle-shaped to round cells arranged around thin-walled branching vascular spaces.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3087
Histopathological diagnosis,Hemangioma ICD-O-3-2 9121/0,Histopathological_diagnosis,Hemangioma_ICD_O_3_2_9121_0,M_Meningioma_100,M_Meningioma_238,C164406,C3085,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",A benign vascular lesion characterized by the formation of capillary-sized or cavernous vascular channels.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3085
Histopathological diagnosis,schwannoma ICD-O-3-2 9560/0,Histopathological_diagnosis,schwannoma_ICD_O_3_2_9560_0,M_Meningioma_100,M_Meningioma_239,C164406,C3269,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",A benign neoplasm of the peripheral nervous system composed of well-differentiated Schwann cells.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3269
Histopathological diagnosis,Metastatic tumor,Histopathological_diagnosis,Metastatic_tumor,M_Meningioma_100,M_Meningioma_240,C164406,C3261,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):","A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site. Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3261
Histopathological diagnosis,Fibrosarcoma/Sarcoma,Histopathological_diagnosis,Fibrosarcoma_Sarcoma,M_Meningioma_100,M_Meningioma_241,C164406,C3043,"The completed activity within the context of a given study that represents the results of a histopathology assessment. NCI 
The findings from a microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains. EXAMPLE(S): HER-2 positive primary breast cancer, adenocarcinoma of the colon OTHER NAME(S): NOTE(S):",A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C164406,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3043
BMI,19-25,BMI,19_25,M_Meningioma_101,M_Meningioma_242,WHO BMI Classification,,Body Mass Index is a person's weight in kilograms divided by the square of height in meters.,Range of Normal (Healthy weight) 25-30,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
BMI,<19,BMI,lt_19,M_Meningioma_101,M_Meningioma_243,WHO BMI Classification,,Body Mass Index is a person's weight in kilograms divided by the square of height in meters.,Range of under weight <19,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
BMI,>30,BMI,gt_30,M_Meningioma_101,M_Meningioma_244,WHO BMI Classification,,Body Mass Index is a person's weight in kilograms divided by the square of height in meters.,Range of over weight >30,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
BMI,25-30,BMI,25_30,M_Meningioma_101,M_Meningioma_245,WHO BMI Classification,,Body Mass Index is a person's weight in kilograms divided by the square of height in meters.,Range of over weight 25-30,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,
parasagittal,right parasagittal,parasagittal,right_parasagittal,M_Meningioma_102,M_Meningioma_246,C4960,C25228 AND C4960,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,Being or located on or directed toward the side of the body to the east when facing north. A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25228 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960
parasagittal,left parasagittal,parasagittal,left_parasagittal,M_Meningioma_102,M_Meningioma_247,C4960,C25229 AND C4960,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,Being or located on or directed toward the side of the body to the west when facing north. A meningioma that affects the superior sagittal sinus and invades the parasagittal angle,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25229 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960
margins,III defined,margins,III_defined,M_Meningioma_103,M_Meningioma_248,C137709,RID5709,Describes the morphologic appearance where a tumor meets the adjacent tissue.,"No clear demarcation of the entire margin or any portion of it from the surrounding tissue (historically, ""ill defined"").",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137709,http://www.radlex.org/RID/RID5709
margins,well defined,margins,well_defined,M_Meningioma_103,M_Meningioma_249,C137709,C81187,Describes the morphologic appearance where a tumor meets the adjacent tissue.,Having a clean and distinct outline as if precisely cut along the edges.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C137709,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C81187
intraventricular,Fourth,intraventricular,Fourth,M_Meningioma_104,M_Meningioma_250,C13731,C54566,Located within a ventricle of the brain or heart.,Following the third position in an ordering or series; coming next after the third and just before the fifth in position.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C13731,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54566
intraventricular,lateral intraventricular,intraventricular,lateral_intraventricular,M_Meningioma_104,M_Meningioma_251,C13731,C25230,Located within a ventricle of the brain or heart.,Situated at or extending to the side.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C13731,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25230
intraventricular,third,intraventricular,third,M_Meningioma_104,M_Meningioma_252,C13731,C25260,Located within a ventricle of the brain or heart.,Following the second position in an ordering or series; coming next after the second and just before the fourth in position.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C13731,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25260
Contrast Enhancement,hetrogeneous,Contrast_Enhancement,hetrogeneous,M_Meningioma_105,M_Meningioma_253,C199692,C28359,The phase of the contrast agent distribution within the body after its administration.,"Made up of elements or ingredients that are not alike. 
The quality or state of consisting of elements that are not of the same kind or nature.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C199692,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28359
Contrast Enhancement,homogenous,Contrast_Enhancement,homogenous,M_Meningioma_105,M_Meningioma_254,C199692,C182329,The phase of the contrast agent distribution within the body after its administration.,Imaging shows a very uniform signal throughout the image.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C199692,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182329
brightness,low,brightness,low,M_Meningioma_106,M_Meningioma_122,C70753,C54722 ,An indication of the relative light intensity of a source or object.,"A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70753,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
brightness,moderate,brightness,moderate,M_Meningioma_106,M_Meningioma_123,C70753,C61376,An indication of the relative light intensity of a source or object.,"Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70753,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
brightness,high,brightness,high,M_Meningioma_106,M_Meningioma_124,C70753,"	C25227",An indication of the relative light intensity of a source or object.,An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70753,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
uniform illumination,low,uniform_illumination,low,M_Meningioma_107,M_Meningioma_122,,C54722,"Radiology uniform illumination refers to the even distribution of brightness or signal intensity across the imaging field of view in radiologic modalities (e.g., X-ray, CT, MRI). It ensures that differences in pixel intensity represent true tissue contrast rather than variations in the imaging systemâ€™s light, detector sensitivity, or RF field.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
uniform illumination,moderate,uniform_illumination,moderate,M_Meningioma_107,M_Meningioma_123,,C61376,"Radiology uniform illumination refers to the even distribution of brightness or signal intensity across the imaging field of view in radiologic modalities (e.g., X-ray, CT, MRI). It ensures that differences in pixel intensity represent true tissue contrast rather than variations in the imaging systemâ€™s light, detector sensitivity, or RF field.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
uniform illumination,high,uniform_illumination,high,M_Meningioma_107,M_Meningioma_124,,"	C25227","Radiology uniform illumination refers to the even distribution of brightness or signal intensity across the imaging field of view in radiologic modalities (e.g., X-ray, CT, MRI). It ensures that differences in pixel intensity represent true tissue contrast rather than variations in the imaging systemâ€™s light, detector sensitivity, or RF field.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
sharpness,low,sharpness,low,M_Meningioma_108,M_Meningioma_122,,C54722 ,"MRI sharpness refers to the clarity with which anatomical edges, boundaries, and fine structures are depicted in an MR image. It reflects the systemâ€™s ability to reproduce rapid changes in signal intensity without blurring, thereby preserving detail needed for accurate diagnosis.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
sharpness,moderate,sharpness,moderate,M_Meningioma_108,M_Meningioma_123,,C61376,"MRI sharpness refers to the clarity with which anatomical edges, boundaries, and fine structures are depicted in an MR image. It reflects the systemâ€™s ability to reproduce rapid changes in signal intensity without blurring, thereby preserving detail needed for accurate diagnosis.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
sharpness,high,sharpness,high,M_Meningioma_108,M_Meningioma_124,,"	C25227","MRI sharpness refers to the clarity with which anatomical edges, boundaries, and fine structures are depicted in an MR image. It reflects the systemâ€™s ability to reproduce rapid changes in signal intensity without blurring, thereby preserving detail needed for accurate diagnosis.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
H & E staining,low,H_E_staining,low,M_Meningioma_109,M_Meningioma_122,C23011,C54722 ,"A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C23011,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
H & E staining,moderate,H_E_staining,moderate,M_Meningioma_109,M_Meningioma_123,C23011,C61376,"A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C23011,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
H & E staining,high,H_E_staining,high,M_Meningioma_109,M_Meningioma_124,C23011,"	C25227","A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C23011,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
contrast,low,contrast,low,M_Meningioma_110,M_Meningioma_122,C70754,C54722 ,The degree of difference between the lightest and darkest areas of an image or object.,"A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70754,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C54722
contrast,moderate,contrast,moderate,M_Meningioma_110,M_Meningioma_123,C70754,C61376,The degree of difference between the lightest and darkest areas of an image or object.,"Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70754,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
contrast,high,contrast,high,M_Meningioma_110,M_Meningioma_124,C70754,"	C25227",The degree of difference between the lightest and darkest areas of an image or object.,An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C70754,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
presence of artifacts,low,presence_of_artifacts,low,M_Meningioma_111,M_Meningioma_122,C75603,C54722 ,"A structure or appearance that is not naturally present, but has been introduced though manipulation.","A minimum level or position or degree; less than normal in degree, intensity or amount.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C75603,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
presence of artifacts,moderate,presence_of_artifacts,moderate,M_Meningioma_111,M_Meningioma_123,C75603,C61376,"A structure or appearance that is not naturally present, but has been introduced though manipulation.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C75603,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
presence of artifacts,high,presence_of_artifacts,high,M_Meningioma_111,M_Meningioma_124,C75603,"	C25227","A structure or appearance that is not naturally present, but has been introduced though manipulation.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C75603,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
Lateral,lateral right,Lateral,lateral_right,M_Meningioma_112,M_Meningioma_255,C25230,C160199,Situated at or extending to the side,A finding indicating the tumor location is on the right side of the specimen.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25230,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160199
Lateral,lateral left,Lateral,lateral_left,M_Meningioma_112,M_Meningioma_256,C25230,C160200,Situated at or extending to the side,A finding indicating the tumor location is on the left side of the specimen.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25230,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C160200
Shape of the lesion,Globular,Shape_of_the_lesion,Globular,M_Meningioma_113,M_Meningioma_257,C25677 AND C3824,C41425,"The spatial arrangement of something as distinct from its substance. A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",A lesion characterized by the presence of one or more nodules.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25677 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3824,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C41425
Shape of the lesion,En-plaque,Shape_of_the_lesion,En_plaque,M_Meningioma_113,M_Meningioma_258,C25677 AND C3824,C42587,"The spatial arrangement of something as distinct from its substance. A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.",Sheet-Like Growth Pattern,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25677 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3824,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C42587
cellularity,moderate,cellularity,moderate,M_Meningioma_114,M_Meningioma_123,C37923,C61376,"The degree, quality, or condition of cells that are present.","Middling or intermediate in degree, quality or extent.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37923,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C61376
cellularity,high,cellularity,high,M_Meningioma_114,M_Meningioma_124,C37923,C25227,"The degree, quality, or condition of cells that are present.",An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C37923,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25227
nuclear cytoplasmic ratio,high,nuclear_cytoplasmic_ratio,high,M_Meningioma_115,M_Meningioma_124,,C37923,the ratio of the cross-sectional area of the nucleus divided by that of cytoplasm ,An elevated level or position or degree; greater than normal in degree or intensity or amount.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://www.spiedigitallibrary.org/journals/journal-of-biomedical-optics/volume-24/issue-10/106502/Determination-of-cell-nucleus-to-cytoplasmic-ratio-using-imaging-flow/10.1117/1.JBO.24.10.106502.full,
nuclear cytoplasmic ratio,normal,nuclear_cytoplasmic_ratio,normal,M_Meningioma_115,M_Meningioma_259,,C14165,the ratio of the cross-sectional area of the nucleus divided by that of cytoplasm ,Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://www.spiedigitallibrary.org/journals/journal-of-biomedical-optics/volume-24/issue-10/106502/Determination-of-cell-nucleus-to-cytoplasmic-ratio-using-imaging-flow/10.1117/1.JBO.24.10.106502.full,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C14165
right parasagittal,anterior,right_parasagittal,anterior,M_Meningioma_116,M_Meningioma_260,C4960,C25231,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,Denoting the front portion of the body or a structure.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25231
right parasagittal,posterior,right_parasagittal,posterior,M_Meningioma_116,M_Meningioma_261,C4960,C25622,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,Denoting the back portion of the body or a structure.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25622
right parasagittal,middle,right_parasagittal,middle,M_Meningioma_116,M_Meningioma_262,C4960,C25569,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,An intermediate part or section; an area that is approximately central within some larger region.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25569
left parasagittal,anterior,left_parasagittal,anterior,M_Meningioma_117,M_Meningioma_260,C4960,C25231,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,Denoting the front portion of the body or a structure.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25231
left parasagittal,posterior,left_parasagittal,posterior,M_Meningioma_117,M_Meningioma_261,C4960,C25622,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,Denoting the back portion of the body or a structure.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25622
left parasagittal,middle,left_parasagittal,middle,M_Meningioma_117,M_Meningioma_262,C4960,C25569,A meningioma that affects the superior sagittal sinus and invades the parasagittal angle.,An intermediate part or section; an area that is approximately central within some larger region.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C4960,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25569
motor weakness,lower limb,motor_weakness,lower_limb,M_Meningioma_118,M_Meningioma_263,"	C182336","	C12742","Impairments of brain function, the nerve or spinal cord that affect a specific region of the body.","The limb that is composed of the hip, thigh, leg and foot.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182336,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12742
motor weakness,upper limb,motor_weakness,upper_limb,M_Meningioma_118,M_Meningioma_264,"	C182336","	C12671","Impairments of brain function, the nerve or spinal cord that affect a specific region of the body.",The part of the forelimb extending from the shoulder to the autopod.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C182336,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C12671
post operative,no of post of scan,post_operative,no_of_post_of_scan,M_Meningioma_119,M_Meningioma_265,C28006,C28006 AND C124281,"After surgery. NCI-GLOSS 
Relating to or occurring during the period immediately following a surgical operation.","After surgery. NCI-GLOSS 
Relating to or occurring during the period immediately following a surgical operation. A measurement of the total number of events that have occurred.",,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28006,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C28006 AND https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C124281
preoperative KPS score,> 80,preoperative_KPS_score,gt_80,M_Meningioma_120,M_Meningioma_266,C100417,,Karnofsky Performance Status Scale (KPS Scale) Karnofsky Performance Status.,A patient with mild symptoms but independent in daily activities may have a preoperative KPS of >80,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C100417,
preoperative KPS score,<80,preoperative_KPS_score,lt_80,M_Meningioma_120,M_Meningioma_267,C100417,,Karnofsky Performance Status Scale (KPS Scale) Karnofsky Performance Status.,A patient requiring significant assistance due to neurological deficits might have a preoperative KPS of <80,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C100417,
immuno-histochemical IHC Markers,MIB-1/Ki67 labeling index (% of positive stained cells for at least 500 tumor cells),immuno_histochemical_IHC_Markers,MIB_1_labeling_index_of_positive_stained_cells_for_at_least_500_tumor_cells,M_Meningioma_121,M_Meningioma_268,C23020,C157250,"A technique used to identify specific molecules in different kinds of tissue. The tissue is treated with antibodies that bind the specific molecule. These are made visible under a microscope by using a color reaction, a radioisotope, colloidal gold, or a fluorescent dye. Immunohistochemistry is used to help diagnose diseases, such as cancer, and to detect the presence of microorganisms. It is also used in basic research to understand how cells grow and differentiate (become more specialized).",The percentage of cells in a sample that are dividing that is determined by immunohistochemical staining techniques using MIB-1 antibody (anti-Ki-67 protein antibody).,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C23020,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C157250
present,absent,present,absent,M_Meningioma_122,M_Meningioma_139,C25626,C48190,Being or existing in a specified place or at the specified time.,Not existing in a specified place at a specified time.,,,http://www.w3.org/2000/01/rdf-schema#subClassOf,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25626,https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C48190

